Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
104000,,Active,1869129,[],CHEMBL913069,Antimicrobial activity against Pseudomonas aeruginosa 2A1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104001,,Active,1869142,[],CHEMBL913070,Antimicrobial activity against Pseudomonas aeruginosa 2C1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104002,,Active,1869149,[],CHEMBL913071,Antimicrobial activity against Pseudomonas aeruginosa 2A2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104003,,Active,1869160,[],CHEMBL913072,Antimicrobial activity against Pseudomonas aeruginosa 2C2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104004,,Active,1869170,[],CHEMBL913073,Antimicrobial activity against Pseudomonas aeruginosa 2A3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104005,,Active,1869181,[],CHEMBL913074,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104006,,Active,1869232,[],CHEMBL913075,Antimicrobial activity against Pseudomonas aeruginosa 2B5 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104007,,Active,1869243,[],CHEMBL913076,Antimicrobial activity against Pseudomonas aeruginosa 2A6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104008,,Active,1869255,[],CHEMBL913077,Antimicrobial activity against Pseudomonas aeruginosa 2F6 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104009,,Active,1869267,[],CHEMBL913078,Antimicrobial activity against Pseudomonas aeruginosa 2A7 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104010,,Active,1869278,[],CHEMBL913079,Antimicrobial activity against Pseudomonas aeruginosa 2A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104011,,Active,1869284,[],CHEMBL913080,Antimicrobial activity against Pseudomonas aeruginosa 3B1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104012,,Active,1869295,[],CHEMBL913081,Antimicrobial activity against Pseudomonas aeruginosa 65.68-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104013,,Active,1869306,[],CHEMBL913082,Antimicrobial activity against Pseudomonas aeruginosa 65.68-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104014,,Active,1869330,[],CHEMBL913083,Antimicrobial activity against Pseudomonas aeruginosa 65.68-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104015,,Active,1869346,[],CHEMBL913085,Antimicrobial activity against Pseudomonas aeruginosa 65.68-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104016,,Active,1869677,[],CHEMBL914141,Antimicrobial activity against Pseudomonas aeruginosa 15H5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,634882,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104017,,Not Active,1917551,[],CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1148734,J Med Chem,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,654120,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
104018,,,2124937,[],CHEMBL935458,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count by rotating disk reactor method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145499,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,705502,=,1,0,=,,Activity,,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,0.4
104019,,,2124941,[],CHEMBL935459,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 10 ug/ml by rotating disk reactor method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145499,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,705502,=,1,0,=,,Activity,,,1.51,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,1.51
104020,,,2124943,[],CHEMBL935460,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 50 ug/ml by rotating disk reactor method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145499,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,705502,=,1,0,=,,Activity,,,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,0.78
104021,,,2124945,[],CHEMBL951948,Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 100 ug/ml by rotating disk reactor method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145499,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,705502,=,1,0,=,,Activity,,,1.36,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,1.36
104022,,,2125299,[],CHEMBL952756,Antimicrobial activity against Mycobacterium abscessus after 3 to 5 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104023,,,2125300,[],CHEMBL952756,Antimicrobial activity against Mycobacterium abscessus after 3 to 5 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104024,,,2125309,[],CHEMBL952757,Antimicrobial activity against Mycobacterium chelonae after 3 to 5 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104025,,,2125310,[],CHEMBL952757,Antimicrobial activity against Mycobacterium chelonae after 3 to 5 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104026,,,2125319,[],CHEMBL952758,Antimicrobial activity against Mycobacterium fortuitum after 3 to 5 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104027,,,2125320,[],CHEMBL952758,Antimicrobial activity against Mycobacterium fortuitum after 3 to 5 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104028,,,2125327,[],CHEMBL952759,Antimicrobial activity against Mycobacterium abscessus CH10 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,128.0
104029,,,2125332,[],CHEMBL938217,Antimicrobial activity against Mycobacterium abscessus R31 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,128.0
104030,,,2125337,[],CHEMBL938218,Antimicrobial activity against Mycobacterium abscessus R39 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
104031,,,2125341,[],CHEMBL938219,Antimicrobial activity against Mycobacterium abscessus NTU445 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104032,,,2125347,[],CHEMBL938220,Antimicrobial activity against Mycobacterium abscessus NTU459 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,8.0
104033,,,2125354,[],CHEMBL938221,Antimicrobial activity against Mycobacterium abscessus R51 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
104034,,,2125357,[],CHEMBL938222,Antimicrobial activity against Mycobacterium abscessus NTU446 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,4.0
104035,,,2125362,[],CHEMBL938223,Antimicrobial activity against Mycobacterium abscessus R47 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104036,,,2125368,[],CHEMBL938224,Antimicrobial activity against Mycobacterium abscessus R50 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104037,,,2125374,[],CHEMBL938225,Antimicrobial activity against Mycobacterium abscessus R54 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
104038,,,2125378,[],CHEMBL938226,Antimicrobial activity against Mycobacterium abscessus R61 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104039,,,2125383,[],CHEMBL938227,Antimicrobial activity against Mycobacterium abscessus R65 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104040,,,2125387,[],CHEMBL938228,Antimicrobial activity against Mycobacterium abscessus R53 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,8.0
104041,,,2125392,[],CHEMBL938229,Antimicrobial activity against Mycobacterium abscessus R49 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104042,,,2125397,[],CHEMBL938230,Antimicrobial activity against Mycobacterium abscessus V120 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,16.0
104043,,,2125402,[],CHEMBL952858,Antimicrobial activity against Mycobacterium fortuitum V13 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,128.0
104044,,,2125407,[],CHEMBL952859,Antimicrobial activity against Mycobacterium fortuitum V61 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,64.0
104045,,,2125411,[],CHEMBL952860,Antimicrobial activity against Mycobacterium fortuitum V146 isolate after 3 to 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145515,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,706129,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC,ug ml-1,UO_0000274,,64.0
104046,,,2126262,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702312,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104047,,,2126263,[],CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702312,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104048,,,2126295,[],CHEMBL934998,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,702312,=,1,0,=,,Activity,%,,94.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,94.0
104049,,,2126313,[],CHEMBL934999,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,702312,=,1,0,=,,Activity,%,,95.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,95.0
104050,,,2126336,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702312,<=,1,1,<=,,MIC50,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104051,,,2126337,[],CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702312,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104052,,,2126371,[],CHEMBL935001,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,702312,=,1,0,=,,Activity,%,,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,22.0
104053,,,2126389,[],CHEMBL935002,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,702312,=,1,0,=,,Activity,%,,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,22.0
104054,,,2127693,[],CHEMBL938380,Antibacterial activity against TEM92 ESBL-producing Acinetobacter baumannii by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1144462,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703562,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
104055,,,2128153,[],CHEMBL936837,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa isolate,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145466,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703985,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104056,,,2128161,[],CHEMBL936838,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145466,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,703985,=,1,0,=,,Activity,%,,55.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,55.0
104057,,,2128699,[],CHEMBL940188,Antimicrobial activity against Acinetobacter baumannii D54 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
104058,,,2128707,[],CHEMBL940190,Antimicrobial activity against Acinetobacter baumannii A24 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
104059,,,2128715,[],CHEMBL940192,Antimicrobial activity against Acinetobacter baumannii A24 in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
104060,,,2128723,[],CHEMBL940194,Antimicrobial activity against Acinetobacter baumannii A24A after 4 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
104061,,,2128731,[],CHEMBL939407,Antimicrobial activity against Acinetobacter baumannii A24B after 4 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
104062,,,2128739,[],CHEMBL939409,Antimicrobial activity against Acinetobacter baumannii A24C after 4 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
104063,,,2128747,[],CHEMBL939411,Antimicrobial activity against Acinetobacter baumannii A24D after 4 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104064,,,2128755,[],CHEMBL939413,Antimicrobial activity against Acinetobacter baumannii A24D after 4 days in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
104065,,,2128763,[],CHEMBL939415,Antimicrobial activity against Acinetobacter baumannii B46 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,24.0
104066,,,2128771,[],CHEMBL921721,Antimicrobial activity against Acinetobacter baumannii B46 in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104067,,,2128779,[],CHEMBL921723,Antimicrobial activity against Acinetobacter baumannii C75 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104068,,,2128787,[],CHEMBL921725,Antimicrobial activity against Acinetobacter baumannii C75 in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1145479,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,704438,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
104069,,,2147921,[],CHEMBL924843,Antimicrobial activity against Escherichia coli BAS849,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,=,1,1,=,,MIC,ug.mL-1,,1.95,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.95
104070,,,2147924,[],CHEMBL924844,Antimicrobial activity against Pseudomonas aeruginosa 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,=,1,1,=,,MIC,ug.mL-1,,0.62,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.62
104071,,,2147927,[],CHEMBL924845,Antimicrobial activity against Staphylococcus aureus 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,=,1,1,=,,MIC,ug.mL-1,,0.62,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.62
104072,,,2147930,[],CHEMBL924831,Antimicrobial activity against Staphylococcus epidermis,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.31
104073,,,2147933,[],CHEMBL924846,Antimicrobial activity against Enterococcus faecium 49624,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,>,1,1,>,,MIC,ug.mL-1,,62.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,62.5
104074,,,2147936,[],CHEMBL924847,Antimicrobial activity against Enterococcus faecalis 29212,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1147979,Nature,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,709997,>,1,1,>,,MIC,ug.mL-1,,62.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,62.5
104075,,,2344598,[],CHEMBL953811,Antimicrobial activity against integron carrying Enterobacteriaceae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1150792,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,793261,=,1,0,=,,Activity,%,,41.8,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,41.8
104076,,,2344612,[],CHEMBL953812,Antimicrobial activity against non-integron carrying Enterobacteriaceae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1150792,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,793261,=,1,0,=,,Activity,%,,8.5,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,,Activity,%,UO_0000187,,8.5
104077,,,2347336,[],CHEMBL957141,"fCmax in Pseudomonas aeruginosa PAO1 infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,0,=,,fc max,mg/L,,19.07,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,fc max,mg/L,,,19.07
104078,,,2347338,[],CHEMBL957158,"fCmax/MIC ratio in Pseudomonas aeruginosa PAO1 infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,0,=,,fc max/MIC,,,19.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fc max/MIC,,,,19.0
104079,,,2347341,[],CHEMBL957149,Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794528,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104080,,,2347342,[],CHEMBL957144,"Half life of free unbound fraction in Pseudomonas aeruginosa PAO1 infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,794528,=,1,1,=,,T1/2,hr,,0.55,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2 unbound fraction,hr,UO_0000032,,0.55
104081,,,2347345,[],CHEMBL957159,"fCmax/MIC ratio in Pseudomonas aeruginosa PAOdeltamutS infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,0,=,,fc max/MIC,,,19.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fc max/MIC,,,,19.0
104082,,,2347346,[],CHEMBL957154,"fAUC (0 to 24 hrs)/MIC ratio in Pseudomonas aeruginosa PAOdeltamutS infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,0,=,,fAUC/MIC,,,43.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fAUC/MIC,,,,43.0
104083,,,2347353,[],CHEMBL957153,"fAUC (0 to 24 hrs)/MIC ratio in Pseudomonas aeruginosa PAO1 infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,0,=,,fAUC/MIC,,,43.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fAUC/MIC,,,,43.0
104084,,,2347356,[],CHEMBL957165,"Antibacterial activity against Pseudomonas aeruginosa PAO1 infected in C57BL/6J mouse assessed as mortality at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,794528,=,1,0,=,,Mortality,%,,66.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Mortality,%,UO_0000187,,66.7
104085,,,2347357,[],CHEMBL957147,"fAUC (0 to 24 hrs) in Pseudomonas aeruginosa PAO1 infected C57BL/6J mouse at 10 mg/kg, ip administered every 6 hrs",A,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,=,1,1,=,,fAUC,ng.hr.mL-1,,42960.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,fAUC,(mg hr) L-1,,,42.96
104086,,,2347358,[],CHEMBL957166,"Antibacterial activity against Pseudomonas aeruginosa PAOdeltamutS infected in C57BL/6J mouse assessed as mortality at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,794528,=,1,0,=,,Mortality,%,,60.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Mortality,%,UO_0000187,,60.0
104087,,,2347369,[],CHEMBL957900,Antibacterial activity against Pseudomonas aeruginosa PAOdeltamutS by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794528,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104088,,Active,2347379,[],CHEMBL957171,"Antibacterial activity against Pseudomonas aeruginosa PAO1 infected in C57BL/6J mouse assessed as lung bacterial count at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,,1,0,,,f %t > MIC,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,f %t > MIC,,,,
104089,,Active,2347380,[],CHEMBL957172,"Antibacterial activity against Pseudomonas aeruginosa PAOdeltamutS infected in C57BL/6J mouse assessed as lung bacterial count at 10 mg/kg, ip administered every 6 hrs",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156416,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,794528,,1,0,,,f %t > MIC,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,f %t > MIC,,,,
104090,,,2347384,[],CHEMBL957903,Antibacterial activity against Escherichia coli 1540 isolate by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793179,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
104091,,,2349391,[],CHEMBL956329,Antimicrobial activity against Acinetobacter baumannii 694 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104092,,,2349404,[],CHEMBL956328,Antimicrobial activity against Acinetobacter baumannii 696 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104093,,,2349417,[],CHEMBL956327,Antimicrobial activity against Acinetobacter baumannii 9043 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104094,,,2349430,[],CHEMBL956325,Antimicrobial activity against Acinetobacter baumannii 695 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104095,,,2349443,[],CHEMBL956324,Antimicrobial activity against Acinetobacter baumannii 501 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104096,,,2349456,[],CHEMBL955555,Antimicrobial activity against Acinetobacter sp. 5227 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,16.0
104097,,,2349469,[],CHEMBL955554,Antimicrobial activity against Acinetobacter sp. 5248 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,MIC,ug ml-1,UO_0000274,,8.0
104098,,,2349482,[],CHEMBL955553,Antimicrobial activity against Pseudomonas putida 12346 isolate harboring bla IMP-1 carrying integron In86 containing aminoglycoside resistance gene aac(6')-3,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,,MIC,ug ml-1,UO_0000274,,16.0
104099,,,2349497,[],CHEMBL955552,Antimicrobial activity against Escherichia coli DH5alpha harboring recombinant pIMPAR31,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
104100,,,2349502,[],CHEMBL956326,Antimicrobial activity against Escherichia coli DH5alpha,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1157360,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794124,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104101,,,2500161,[],CHEMBL1019518,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.047
104102,,,2500167,[],CHEMBL1019517,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.125
104103,,,2500175,[],CHEMBL1019520,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
104104,,,2500177,[],CHEMBL1019521,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.38
104105,,,2500180,[],CHEMBL1019516,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.5
104106,,,2500192,[],CHEMBL1019522,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
104107,,,2500197,[],CHEMBL1019515,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.5
104108,,,2500198,[],CHEMBL1019519,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780054,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.5
104109,,,2576274,[],CHEMBL992870,Antimicrobial activity against wild type vancomycin-intermediate resistant Staphylococcus aureus Mu50 by microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742978,>=,1,1,>=,,MIC,ug.mL-1,,2048.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2048.0
104110,,,2576291,[],CHEMBL992872,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 vraG mutant microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742978,>=,1,1,>=,,MIC,ug.mL-1,,2048.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2048.0
104111,,,2576308,[],CHEMBL992871,Antimicrobial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 graR mutant microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1155143,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,742978,>=,1,1,>=,,MIC,ug.mL-1,,2048.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2048.0
104112,,Not Active,2591887,[],CHEMBL965578,Inhibition of mouse brain MAOA,B,,,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,725521,,1,0,,,Activity,,,,CHEMBL3681,Mus musculus,Monoamine oxidase A,10090.0,,,Activity,,,,
104113,,Not Active,2591973,[],CHEMBL965580,Inhibition of mouse brain MAOB,B,,,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,725521,,1,0,,,Activity,,,,CHEMBL3050,Mus musculus,Monoamine oxidase B,10090.0,,,Activity,,,,
104114,,,2612082,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104115,,,2612083,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104116,,,2612084,[],CHEMBL1015965,Antibacterial activity against Pseudomonas aeruginosa clinical isolate by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
104117,,,2612093,[],CHEMBL1015966,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104118,,,2612102,[],CHEMBL1015967,Antibacterial activity against wild type Pseudomonas aeruginosa isolate by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104119,,,2612163,[],CHEMBL1015981,Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104120,,,2612167,[],CHEMBL1015982,Antibacterial activity against MexXY-OprM pump-independent aminoglycoside-resistant Pseudomonas aeruginosa isolate by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104121,,,2612171,[],CHEMBL1016786,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, ANT(2'')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104122,,,2612175,[],CHEMBL1016787,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104123,,,2612179,[],CHEMBL1016788,Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing ANT(2'')-1 by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104124,,,2612183,[],CHEMBL1016789,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing AAC(6')-1, ANT(2'')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104125,,,2612187,[],CHEMBL1016790,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1, ANT(2'')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104126,,,2612191,[],CHEMBL1016791,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(3')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104127,,,2612195,[],CHEMBL1016792,"Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing MexXY-OprM pump, AAC(6')-1, AAC(3')-1 by macrodilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104128,,,2612199,[],CHEMBL1016793,Antibacterial activity against aminoglycoside-resistant Pseudomonas aeruginosa isolate expressing AAC(6')-1 by macrodilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,731748,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104129,,,2612214,[],CHEMBL1015964,Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as resistant rate by macrodilution technique,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,731748,=,1,0,=,,Activity,%,,21.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,21.7
104130,,,2612224,[],CHEMBL1016799,Antibacterial activity against Pseudomonas aeruginosa clinical isolates assessed as susceptible rate by macrodilution technique,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152825,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,731748,=,1,0,=,,Activity,%,,77.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,77.5
104131,,,2624191,[],CHEMBL1007463,Binding affinity to A-site RNA,B,,,BAO_0000034,BAO_0000225,nucleic acid format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1136940,J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,7.1,0,http://www.openphacts.org/units/Nanomolar,756532,=,1,1,=,,Kd,nM,,80.0,CHEMBL345,,Nucleic Acid,,,,Kd,nM,UO_0000065,,80.0
104132,,,2631770,[],CHEMBL1004059,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS3 transconjugant from Citrobacter freundii 64 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784120,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104133,,,2631771,[],CHEMBL1004060,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS4 transconjugant from Enterobacter cloacae 91 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784120,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104134,,,2631772,[],CHEMBL1006592,Antimicrobial activity against azide-resistant aac(6')-Ib-cr deficient Escherichia coli J53 qnrA1 bearing pHS5 transconjugant from Enterobacter cloacae 641 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784120,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104135,,,2631773,[],CHEMBL1006593,Antimicrobial activity against azide-resistant aac(6')-Ib-cr expressing Escherichia coli J53 qnrA1 bearing pHS6 transconjugant from Escherichia coli 650 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784120,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104136,,,2631774,[],CHEMBL1006594,Antimicrobial activity against azide-resistant Escherichia coli J53 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137652,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784120,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104137,,,2633767,[],CHEMBL957049,Antibacterial activity against Acinetobacter baumannii isolate A expressing 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
104138,,,2633774,[],CHEMBL957050,Antibacterial activity against Acinetobacter baumannii isolate B expressing 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
104139,,,2633776,[],CHEMBL957051,Antibacterial activity against Acinetobacter baumannii isolate C expressing 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
104140,,,2633778,[],CHEMBL957052,Antibacterial activity against Acinetobacter baumannii isolate D expressing 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
104141,,,2633780,[],CHEMBL957797,Antibacterial activity against Acinetobacter baumannii isolate E expressing 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,512.0
104142,,,2633783,[],CHEMBL966089,Antibacterial activity against Escherichia coli DH10B expressing Acinetobacter baumannii isolate B 16S rRNA methylase armA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1137657,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,784308,>=,1,1,>=,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104143,,,2662344,[],CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
104144,,,2662345,[],CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104145,,,2662346,[],CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104146,,,2662347,[],CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104147,,,2662348,[],CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104148,,,2662349,[],CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104149,,,2662350,[],CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818995,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104150,,,2663828,[],CHEMBL958786,Antimicrobial activity against Pseudomonas aeruginosa GY3 producing blaVIM-2 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817429,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104151,,,2663833,[],CHEMBL953433,Antimicrobial activity against carbapenem-resistant Pseudomonas aeruginosa clinical isolate assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,817429,=,1,0,=,,Activity,%,,44.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,44.0
104152,,,2663834,[],CHEMBL953432,Antimicrobial activity against carbapenem-susceptible Pseudomonas aeruginosa clinical isolate assessed as resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,817429,=,1,0,=,,Activity,%,,9.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,9.0
104153,,,2663876,[],CHEMBL957126,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring pV2GY3 with blaVIM-2 and aac(6)'-32 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817429,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104154,,,2663877,[],CHEMBL958787,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817429,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.75
104155,,,2663882,[],CHEMBL963911,Antimicrobial activity against Escherichia coli XL1-Blue by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817429,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
104156,,,2663883,[],CHEMBL963912,Antimicrobial activity against Escherichia coli XL1-Blue harboring pGTAAC-32 with cloned aac(6)'-32 by E-test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151445,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817429,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.0
104157,,,2672727,[],CHEMBL1035433,Total body clearance in human,A,,,BAO_0002759,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,820324,=,1,1,=,,CL,mL.min-1.kg-1,,1.6,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL,ml/min.kg,,,1.6
104158,,,2672728,[],CHEMBL1035434,Renal clearance in human,A,,,BAO_0002773,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1151930,J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,820324,=,1,1,=,,CL_renal,mL.min-1.kg-1,,1.19,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,CL_renal,ml/min.kg,,,1.19
104159,,,2680224,[],CHEMBL1057970,Antibacterial activity against Escherichia coli isolate ARS3 carrying pARS3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823208,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104160,,,2680241,[],CHEMBL1057971,Antibacterial activity against Escherichia coli CSH-2 carrying Escherichia coli ARS3 pARS3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823208,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104161,,,2680629,[],CHEMBL1057972,Antibacterial activity against Escherichia coli CSH-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823208,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.06
104162,,,2680646,[],CHEMBL1057973,Antibacterial activity against Escherichia coli JM109 carrying pMCL-BE by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823208,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104163,,,2680663,[],CHEMBL1057974,Antibacterial activity against Escherichia coli JM109 carrying pMCL210 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1152454,Antimicrob Agents Chemother,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,823208,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.13
104164,,,2720399,[],CHEMBL1056762,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1153587,Eur J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829861,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
104165,,,2720403,[],CHEMBL1056761,Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1153587,Eur J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829861,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104166,,,2720410,[],CHEMBL1056763,Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1153587,Eur J Med Chem,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829861,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
104167,,,2995930,[],CHEMBL1044332,Antibacterial activity against Acinetobacter lwoffii ATCC 17925 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,0.5
104168,,,2995931,[],CHEMBL1044333,Antibacterial activity against APH30-VIa expressing Acinetobacter lwoffii AI.88-483 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,1.0
104169,,,2995932,[],CHEMBL1044334,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104170,,,2995933,[],CHEMBL1044335,Antibacterial activity against AAC6'-2a expressing Pseudomonas aeruginosa F03 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
104171,,,2995934,[],CHEMBL1044336,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PT629 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104172,,,2995935,[],CHEMBL1046944,Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
104173,,,2995936,[],CHEMBL1046945,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104174,,,2995937,[],CHEMBL1046946,Antibacterial activity against AAC6'-2b expressing Escherichia coli PAZ505H8101 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
104175,,,2995938,[],CHEMBL1046947,Antibacterial activity against ANT2'-2a expressing Escherichia coli L58058.1 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104176,,,2995948,[],CHEMBL1046955,Antibacterial activity against R-methylase expressing Citrobacter amalonaticus 06AB0010 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL615077,Citrobacter amalonaticus,Citrobacter amalonaticus,35703.0,,,MIC,ug ml-1,UO_0000274,,128.0
104177,,,2995949,[],CHEMBL1046956,Antibacterial activity against R-methylase expressing Escherichia coli 06AB003 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104178,,,2995950,[],CHEMBL1046957,Antibacterial activity against R-methylase expressing Enterobacter aerogenes 06AB008 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,128.0
104179,,,2995987,[],CHEMBL1046948,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104180,,,2995988,[],CHEMBL1046949,Antibacterial activity against MexCD expressing Pseudomonas aeruginosa PA01 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104181,,,2995989,[],CHEMBL1046950,Antibacterial activity against MexEF expressing Pseudomonas aeruginosa PA03 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104182,,,2995990,[],CHEMBL1046951,Antibacterial activity against MexAB expressing Pseudomonas aeruginosa PA21 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104183,,,2995991,[],CHEMBL1046952,Antibacterial activity against MexXY expressing Pseudomonas aeruginosa PA22 after 24 hrs by geometric microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104184,,,2995992,[],CHEMBL1046953,"Antibacterial activity against TriABC expressing MexAB, MexCD, MexEF, MexXY deleted Pseudomonas aeruginosa PA405 after 24 hrs by geometric microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104185,,,2995993,[],CHEMBL1046954,"Antibacterial activity against MexAB, MexCD, MexEF, MexXY, TriABC deleted Pseudomonas aeruginosa PA406 after 24 hrs by geometric microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1156794,J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,856581,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104186,,,3093735,[],CHEMBL1070816,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BAA-1605 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,884120,=,1,1,=,,MIC,nM,,6250.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,6.25
104187,,,3093745,[],CHEMBL1070812,Antibacterial activity against Acinetobacter baumannii ATCC 19606 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,884120,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,25.0
104188,,,3093776,[],CHEMBL1070813,Antibacterial activity against Acinetobacter baumannii UH8407 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,884120,=,1,1,=,,MIC,nM,,200000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,200.0
104189,,,3093777,[],CHEMBL1070815,Antibacterial activity against Acinetobacter baumannii AB0043 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,884120,=,1,1,=,,MIC,nM,,200000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,200.0
104190,,,3093786,[],CHEMBL1070814,Antibacterial activity against Acinetobacter baumannii 3304 after 16 to 20 hrs by microdilution susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1159075,Bioorg Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,884120,>,1,1,>,,MIC,nM,,400000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,400.0
104191,,,3324358,[],CHEMBL1167513,Antibacterial activity against Escherichia coli after 24 hrs by micro broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1165880,Eur J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,920456,=,1,0,=,,MIC50,mmol/ml,,1.07,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,mmol/ml,,,1.07
104192,,,3324359,[],CHEMBL1167514,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1165880,Eur J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,920456,=,1,0,=,,MIC50,mmol/ml,,0.53,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mmol/ml,,,0.53
104193,,,3324360,[],CHEMBL1167515,Antibacterial activity against Klebsiella pneumoniae ATCC 27736 after 24 hrs by micro broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1165880,Eur J Med Chem,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,920456,=,1,0,=,,MIC50,mmol/ml,,2.14,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,mmol/ml,,,2.14
104194,,,3385348,[],CHEMBL1220253,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52145R assessed as growth inhibition by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930457,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104195,,,3385361,[],CHEMBL1220254,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrB containing isogenic acrB knockout assessed as growth inhibition by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930457,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.125
104196,,,3385374,[],CHEMBL1220255,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrR containing isogenic acrR knockout assessed as growth inhibition by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212756,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930457,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104197,,,3386499,[],CHEMBL1218425,Antibacterial activity against Acinetobacter baumannii BM4454 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
104198,,,3386500,[],CHEMBL1218424,Antibacterial activity against Acinetobacter baumannii BM4587 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.75
104199,,,3386501,[],CHEMBL1218426,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4665 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
104200,,,3386502,[],CHEMBL1218427,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4666 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
104201,,,3386503,[],CHEMBL1218428,Antibacterial activity against Acinetobacter baumannii BM4467 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
104202,,,3386504,[],CHEMBL1218429,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4668 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
104203,,,3386505,[],CHEMBL1218430,Antibacterial activity against Acinetobacter baumannii CIP70-10 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
104204,,,3386506,[],CHEMBL1218431,Antibacterial activity against multidrug-resistant Acinetobacter baumannii AYE by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
104205,,,3386507,[],CHEMBL1218432,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4675 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
104206,,,3386508,[],CHEMBL1218433,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4676 by antimicrobial susceptibility assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930252,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,96.0
104207,,,3388549,[],CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
104208,,,3388557,[],CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104209,,,3388565,[],CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104210,,,3388573,[],CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
104211,,,3388581,[],CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
104212,,,3388589,[],CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104213,,,3388597,[],CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104214,,,3388605,[],CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,128.0
104215,,,3388613,[],CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104216,,,3388621,[],CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104217,,,3388629,[],CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104218,,,3388637,[],CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104219,,,3388645,[],CHEMBL1216185,Antimicrobial activity against drug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,128.0
104220,,,3388653,[],CHEMBL1216186,Antimicrobial activity against multidrug resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,256.0
104221,,,3388661,[],CHEMBL1216187,Antimicrobial activity against imipenem resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104222,,,3388669,[],CHEMBL1216188,Antimicrobial activity against Ceftazidime resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,4.0
104223,,,3388677,[],CHEMBL1216189,Antimicrobial activity against piperacillin-tazobactam resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,4.0
104224,,,3388685,[],CHEMBL1216190,Antimicrobial activity against tobramycin resistant Pseudomonas aeruginosa isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212785,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,929941,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,128.0
104225,,,3397355,[],CHEMBL1220554,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104226,,,3397356,[],CHEMBL1220555,Antibacterial activity against Pseudomonas aeruginosa PA899 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104227,,,3397357,[],CHEMBL1220559,Antibacterial activity against Pseudomonas aeruginosa PA880 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104228,,,3397358,[],CHEMBL1220560,Antibacterial activity against Pseudomonas aeruginosa PA881 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104229,,,3397359,[],CHEMBL1220561,Antibacterial activity against Pseudomonas aeruginosa PA1036 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104230,,,3397360,[],CHEMBL1220566,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104231,,,3397361,[],CHEMBL1220567,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104232,,,3397362,[],CHEMBL1220568,Antibacterial activity against Pseudomonas aeruginosa PA899 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104233,,,3397363,[],CHEMBL1220706,Antibacterial activity against Pseudomonas aeruginosa PA880 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104234,,,3397364,[],CHEMBL1220707,Antibacterial activity against Pseudomonas aeruginosa PA881 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104235,,,3397365,[],CHEMBL1220708,Antibacterial activity against Pseudomonas aeruginosa PA1036 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104236,,,3397366,[],CHEMBL1220714,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104237,,,3397367,[],CHEMBL1220713,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104238,,,3397368,[],CHEMBL1220715,Antibacterial activity against Pseudomonas aeruginosa PA899 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104239,,,3397369,[],CHEMBL1220717,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104240,,,3397370,[],CHEMBL1220719,Antibacterial activity against Pseudomonas aeruginosa PA880 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104241,,,3397371,[],CHEMBL1220720,Antibacterial activity against Pseudomonas aeruginosa PA881 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104242,,,3397372,[],CHEMBL1220721,Antibacterial activity against Pseudomonas aeruginosa PA1036 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104243,,,3397373,[],CHEMBL1220722,Antibacterial activity against Pseudomonas aeruginosa PA5026 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104244,,,3397374,[],CHEMBL1220726,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,<=,1,1,<=,,TIME,hr,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.5
104245,,,3397377,[],CHEMBL1220072,Antibacterial activity against Pseudomonas aeruginosa PA1042 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104246,,,3397383,[],CHEMBL1220018,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,0,=,,BBC,ug ml-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,BBC,ug ml-1,UO_0000274,,1.0
104247,,,3397384,[],CHEMBL1220019,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,0,=,,BBC,ug ml-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,BBC,ug ml-1,UO_0000274,,1.0
104248,,,3397385,[],CHEMBL1220544,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,0,=,,BBC,ug ml-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,BBC,ug ml-1,UO_0000274,,1.0
104249,,,3397389,[],CHEMBL1220547,Antibacterial activity against Pseudomonas aeruginosa PA880 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104250,,,3397390,[],CHEMBL1220549,Antibacterial activity against Pseudomonas aeruginosa PA1036 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104251,,,3397392,[],CHEMBL1220557,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
104252,,,3397393,[],CHEMBL1220570,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
104253,,,3397394,[],CHEMBL1220571,Antibacterial activity against Pseudomonas aeruginosa PA5043 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
104254,,,3397395,[],CHEMBL1220709,Antibacterial activity against Pseudomonas aeruginosa PA5026 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
104255,,,3397396,[],CHEMBL1220718,Antibacterial activity against Pseudomonas aeruginosa PA5043 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
104256,,,3397402,[],CHEMBL1220020,Antibacterial activity against Pseudomonas aeruginosa PA5063 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,0,=,,BBC,ug ml-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,BBC,ug ml-1,UO_0000274,,2.0
104257,,,3397405,[],CHEMBL1220548,Antibacterial activity against Pseudomonas aeruginosa PA881 by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104258,,,3397408,[],CHEMBL1220070,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 0.25 ug/ml up to 48 hrs in presence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,2.0
104259,,,3397410,[],CHEMBL1220558,Antibacterial activity against Pseudomonas aeruginosa PA5043 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
104260,,,3397411,[],CHEMBL1220562,Antibacterial activity against Pseudomonas aeruginosa PA5026 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
104261,,,3397412,[],CHEMBL1220712,Antibacterial activity against Pseudomonas aeruginosa PA5020 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
104262,,,3397413,[],CHEMBL1220725,Antibacterial activity against Pseudomonas aeruginosa PA5020 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
104263,,,3397419,[],CHEMBL1220067,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 4 times MIC up to 48 hrs in presence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,2.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,2.7
104264,,,3397420,[],CHEMBL1220066,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 2 times MIC up to 48 hrs in presence of cystic fibrosis patient sputum,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,2.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.2
104265,,,3397424,[],CHEMBL1220068,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 8 times MIC up to 48 hrs in presence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,3.0
104266,,,3397427,[],CHEMBL1220069,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 0.25 ug/ml up to 48 hrs in absence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,3.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,3.7
104267,,,3397428,[],CHEMBL1220729,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 2 times MIC up to 48 hrs in absence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,3.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,3.7
104268,,,3397436,[],CHEMBL1220730,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 4 times MIC up to 48 hrs in absence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,4.0
104269,,,3397437,[],CHEMBL1220064,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM assessed as reduction in log CFU/ml at 8 times MIC up to 48 hrs in absence of cystic fibrosis patient sputum,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,930454,=,1,0,=,,Activity,log10CFU/ml,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,log10CFU/ml,,,4.0
104270,,,3397440,[],CHEMBL1220556,Antibacterial activity against Pseudomonas aeruginosa PA1022 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104271,,,3397441,[],CHEMBL1220563,Antibacterial activity against Pseudomonas aeruginosa PA876 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104272,,,3397442,[],CHEMBL1220565,Antibacterial activity against Pseudomonas aeruginosa PA5020 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104273,,,3397443,[],CHEMBL1220569,Antibacterial activity against Pseudomonas aeruginosa PA1022 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104274,,,3397444,[],CHEMBL1220710,Antibacterial activity against Pseudomonas aeruginosa PA876 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104275,,,3397445,[],CHEMBL1220716,Antibacterial activity against Pseudomonas aeruginosa PA1022 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104276,,,3397446,[],CHEMBL1220723,Antibacterial activity against Pseudomonas aeruginosa PA876 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104277,,,3397447,[],CHEMBL1220724,Antibacterial activity against Pseudomonas aeruginosa PA861 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
104278,,,3397456,[],CHEMBL1220543,Antibacterial activity against Pseudomonas aeruginosa PA5043 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,0,=,,BBC,ug ml-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,BBC,ug ml-1,UO_0000274,,8.0
104279,,,3397461,[],CHEMBL1220019,Antibacterial activity against Pseudomonas aeruginosa PA1042 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104280,,,3397462,[],CHEMBL1220553,Antibacterial activity against Pseudomonas aeruginosa PA5020 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104281,,,3397464,[],CHEMBL1220564,Antibacterial activity against Pseudomonas aeruginosa PA861 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.2 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,8.0
104282,,,3397465,[],CHEMBL1220711,Antibacterial activity against Pseudomonas aeruginosa PA861 assessed as time required for reduction of bacterial load to 3 log CFU/ml at 0.6 mg/ml up to 48 hrs by time-kill assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,930454,=,1,1,=,,TIME,hr,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,8.0
104283,,,3397471,[],CHEMBL1220075,Antibacterial activity against Pseudomonas aeruginosa PA5043 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104284,,,3397477,[],CHEMBL1220552,Antibacterial activity against Pseudomonas aeruginosa PA861 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104285,,,3397505,[],CHEMBL1220551,Antibacterial activity against Pseudomonas aeruginosa PA876 by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104286,,,3397506,[],CHEMBL1220546,Antibacterial activity against Pseudomonas aeruginosa PA1022 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104287,,,3397508,[],CHEMBL1220550,Antibacterial activity against Pseudomonas aeruginosa PA5026 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104288,,,3397533,[],CHEMBL1220012,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104289,,,3397534,[],CHEMBL1220013,Antibacterial activity against Burkholderia cepacia clinical isolates by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104290,,,3397535,[],CHEMBL1220014,Antibacterial activity against Stenotrophomonas maltophilia by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104291,,,3397536,[],CHEMBL1220015,Antibacterial activity against Alcaligenes xylosoxidans by broth dilution method,F,,,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,32.0
104292,,,3397537,[],CHEMBL1220016,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,128.0
104293,,,3397538,[],CHEMBL1220017,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.125
104294,,,3397563,[],CHEMBL1220074,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104295,,,3397564,[],CHEMBL1220073,Antibacterial activity against Pseudomonas aeruginosa PA5063 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104296,,,3397565,[],CHEMBL1220071,Antibacterial activity against Pseudomonas aeruginosa PA1054 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104297,,,3397566,[],CHEMBL1220545,Antibacterial activity against Pseudomonas aeruginosa PA899 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104298,,,3397567,[],CHEMBL1220727,Antibacterial activity against Pseudomonas aeruginosa PAM1032 overexpressing multidrug efflux pump MexAB-OprM by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104299,,,3397568,[],CHEMBL1220018,Antibacterial activity against Pseudomonas aeruginosa PA1054 assessed as inhibition of biofilm formation by microtiter plate reader assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104300,,,3397591,[],CHEMBL1220012,Antibacterial activity against Pseudomonas aeruginosa by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104301,,,3397592,[],CHEMBL1220013,Antibacterial activity against Burkholderia cepacia clinical isolates by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104302,,,3397593,[],CHEMBL1220014,Antibacterial activity against Stenotrophomonas maltophilia by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104303,,,3397594,[],CHEMBL1220015,Antibacterial activity against Alcaligenes xylosoxidans by broth dilution method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
104304,,,3397595,[],CHEMBL1220016,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,128.0
104305,,,3397596,[],CHEMBL1220017,Antibacterial activity against methicillin-sensitive Staphylococcus aureus by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1212734,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930454,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104306,,,3451322,[],CHEMBL1245634,Antibacterial activity against Pseudomonas aeruginosa assessed as percent nonsusceptible isolates by broth microdilution assay,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,952540,=,1,0,=,,Activity,%,,33.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,33.9
104307,,,3452204,[],CHEMBL1245371,Antimicrobial activity against Pseudomonas aeruginosa isolate U9-19005 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104308,,,3452205,[],CHEMBL1245372,Antimicrobial activity against Pseudomonas aeruginosa isolate PA66 producing metallo-beta-lactamase VIM4 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104309,,,3452206,[],CHEMBL1245373,Antimicrobial activity against Pseudomonas aeruginosa isolate AK5493 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104310,,,3452207,[],CHEMBL1245374,Antimicrobial activity against Pseudomonas aeruginosa isolate B4-25753 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104311,,,3452208,[],CHEMBL1245375,Antimicrobial activity against Pseudomonas aeruginosa isolate K34-73 producing metallo-beta-lactamase VIM4 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104312,,,3452209,[],CHEMBL1245376,Antimicrobial activity against Pseudomonas aeruginosa isolate K34-7 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104313,,,3452210,[],CHEMBL1245377,Antimicrobial activity against Pseudomonas aeruginosa isolate BU-20287 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104314,,,3452211,[],CHEMBL1245378,Antimicrobial activity against Pseudomonas aeruginosa isolate BU-43038 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104315,,,3452212,[],CHEMBL1245379,Antimicrobial activity against Pseudomonas aeruginosa isolate BU-36178 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104316,,,3452213,[],CHEMBL1245380,Antimicrobial activity against Pseudomonas aeruginosa isolate BNL-1681 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104317,,,3452214,[],CHEMBL1245381,Antimicrobial activity against Pseudomonas aeruginosa isolate OS-210 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104318,,,3452215,[],CHEMBL1245382,Antimicrobial activity against Pseudomonas aeruginosa isolate K44-24 producing metallo-beta-lactamase IMP14 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104319,,,3452216,[],CHEMBL1245383,Antimicrobial activity against Pseudomonas aeruginosa isolate K45-32 producing metallo-beta-lactamase VIM2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240351,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953330,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104320,,,3452586,[],CHEMBL1245624,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 3D2 GM2 harboring acquired beta-lactamase BEL-3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104321,,,3452588,[],CHEMBL1245623,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 3C9 GM1 harboring acquired beta-lactamase OXA-144 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104322,,,3452589,[],CHEMBL1245622,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 3C8 GM1 harboring acquired beta-lactamase OXA-144 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104323,,,3452590,[],CHEMBL1245621,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 3C1 VAL6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
104324,,,3452591,[],CHEMBL1245620,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1D5 SA1 harboring acquired beta-lactamase VIM-2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104325,,,3452592,[],CHEMBL1245619,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1B2 RCA2 harboring acquired beta-lactamase PER-1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
104326,,,3452593,[],CHEMBL1245618,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1E3 PpA2 harboring acquired beta-lactamase OXA-101 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104327,,,3452594,[],CHEMBL1245617,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1E2 PpA1 harboring acquired beta-lactamase OXA-144 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104328,,,3452595,[],CHEMBL1245616,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1E1 PpA1 harboring acquired beta-lactamase OXA-144 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104329,,,3452596,[],CHEMBL1245615,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1C3 PTOL1 harboring acquired beta-lactamase OXA-17 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104330,,,3452597,[],CHEMBL1245614,Antibacterial activity against carbapenem-resistant Pseudomonas aeruginosa isolate 1C2 PTOL1 harboring beta-lactamase OXA-17 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240358,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952540,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104331,,Active,3452625,[],CHEMBL1247668,Antibacterial activity against Acinetobacter baumannii ATCC 17978 isolated from human CSF,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104332,,Not Active,3452626,[],CHEMBL1247669,Antibacterial activity against Acinetobacter baumannii isolate 510 isolated from human sputum,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104333,,Not Active,3452627,[],CHEMBL1247670,Antibacterial activity against Acinetobacter baumannii isolate 2824 isolated from human urine,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104334,,Not Active,3452628,[],CHEMBL1247671,Antibacterial activity against Acinetobacter baumannii isolate 2898 isolated from human ankle,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104335,,Not Active,3452629,[],CHEMBL1247672,Antibacterial activity against Acinetobacter baumannii isolate 4860 isolated from human urine,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104336,,Not Active,3452630,[],CHEMBL1247673,Antibacterial activity against Acinetobacter baumannii isolate 5191 isolated from human urine,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240380,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,953466,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104337,,,3454654,[],CHEMBL1248816,Antimicrobial activity against Escherichia coli assessed as nonsusceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240391,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,953204,=,1,0,=,,Activity,%,,69.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,69.0
104338,,,3454658,[],CHEMBL1248818,Antimicrobial activity against CTX-M15/CTX-M14 ESBL producing Escherichia coli ST131 clonal complex isolate assessed as nonsusceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240391,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,953204,=,1,0,=,,Activity,%,,93.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,93.0
104339,,,3454659,[],CHEMBL1248817,Antimicrobial activity against ESBL producing Escherichia coli assessed as nonsusceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1240391,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,953204,=,1,0,=,,Activity,%,,49.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,49.0
104340,,,3474122,[],CHEMBL1265017,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 7.0 by bioluminescence assay,F,,,BAO_0000188,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,EC50,ug.mL-1,,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,EC50,ug ml-1,UO_0000274,,1.0
104341,,,3474125,[],CHEMBL1265018,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 5.7 by bioluminescence assay,F,,,BAO_0000188,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,EC50,ug.mL-1,,19.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,EC50,ug ml-1,UO_0000274,,19.0
104342,,,3474128,[],CHEMBL1265016,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 7.0 by bioluminescence assay,F,,,BAO_0000188,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,EC50,ug.mL-1,,2.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,EC50,ug ml-1,UO_0000274,,2.5
104343,,,3474131,[],CHEMBL1265015,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 5.7 by bioluminescence assay,F,,,BAO_0000188,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,EC50,ug.mL-1,,75.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,EC50,ug ml-1,UO_0000274,,75.0
104344,,,3474134,[],CHEMBL1265014,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 7.0 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,4.0
104345,,,3474137,[],CHEMBL1265012,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 at pH 5.7 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,MIC,ug.mL-1,,125.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,125.0
104346,,,3474140,[],CHEMBL1265013,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 7.0 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,8.0
104347,,,3474143,[],CHEMBL1265011,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 at pH 5.7 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959956,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,250.0
104348,,Not Active,3474151,[],CHEMBL1265003,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 cells at 50 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
104349,,Active,3474154,[],CHEMBL1265021,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 infected in mouse J774A.1 cells at 50 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
104350,,Active,3474157,[],CHEMBL1265001,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 assessed as log reduction in viable counts at 150 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
104351,,Active,3474160,[],CHEMBL1265020,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 assessed as log reduction in viable counts at 150 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
104352,,Active,3474168,[],CHEMBL1264996,Reduction in light emission by Salmonella enterica serovars virchow isolate 101591 infected in mouse J774A.1 cells after 5 mins,F,,,BAO_0000375,BAO_0000219,cell-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
104353,,Active,3474174,[],CHEMBL1265004,Antibacterial activity against Salmonella enterica serovars Typhimurium ATCC 14028 infected in mouse J774A.1 macrophage assessed as log reduction in viable counts at 150 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,Activity,,,,
104354,,Active,3474177,[],CHEMBL1265022,Antibacterial activity against Salmonella enterica serovars virchow isolate 101591 infected in mouse J774A.1 macrophage assessed as log reduction in viable counts at 150 ug/ml after 1hr,F,,,BAO_0000375,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255258,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,959956,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
104355,,,3475063,[],CHEMBL1264028,Antimicrobial activity against Escherichia coli isolate DH10B by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960924,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104356,,,3475082,[],CHEMBL1263846,Antimicrobial activity against Escherichia coli MRY04-1060 expressing qepA gene by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960924,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104357,,,3475083,[],CHEMBL1263847,Antimicrobial activity against Escherichia coli MRY05-3283 expressing qepA and rmtB gene by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960924,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104358,,,3475084,[],CHEMBL1264026,Antimicrobial activity against Escherichia coli DH10B harboring p041060 carrying qepA gene by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960924,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104359,,,3475085,[],CHEMBL1264027,Antimicrobial activity against Escherichia coli DH10B harboring p05283 carrying qepA and rmtB gene by agar dilution CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960924,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104360,,,3478629,[],CHEMBL1266063,"Antibacterial activity against Klebsiella pneumoniae isolate VA367 with blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, blaSHV-12, aac(6')-1b genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961477,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104361,,,3478649,[],CHEMBL1266065,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA367 containing blaKPC-3, qnrB19, blaTEM-1, blaSHV-11, aac(6')-1b genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961477,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104362,,,3478664,[],CHEMBL1266067,"Antibacterial activity against Klebsiella pneumoniae isolate VA375 with blaKPC-3, qnrA1, blaTEM-1, blaSHV-11 genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961477,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104363,,,3478679,[],CHEMBL1266069,"Antibacterial activity against Escherichia coli J53 transconjugated with Klebsiella pneumoniae isolate VA375 containing qnrA1, blaTEM-1, blaSHV-11genes by CLSI method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961477,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
104364,,,3478694,[],CHEMBL1266200,Antibacterial activity against Escherichia coli J53 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255372,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961477,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
104365,,,3482103,[],CHEMBL1265097,Antibacterial activity against Escherichia coli JM83 producing aminoglycoside 2''-2a phosphotransferase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104366,,,3482104,[],CHEMBL1265098,Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase N196D/D268N mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104367,,,3482105,[],CHEMBL1265099,Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H/D268N mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104368,,,3482106,[],CHEMBL1265100,Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104369,,,3482107,[],CHEMBL1265101,Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a N196D mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
104370,,,3482108,[],CHEMBL1265102,Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a D268N mutant by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
104371,,,3482109,[],CHEMBL1265614,Antibacterial activity against Escherichia coli JM83 harboring empty pHF022 vector by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960985,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
104372,,,3482141,[],CHEMBL1265615,Activity of Aminoglycoside 2'-phosphotransferase 2a using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000481,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,=,1,0,=,,Kcat,/s,,26.1,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,26.1
104373,,,3482148,[],CHEMBL1265615,Activity of Aminoglycoside 2'-phosphotransferase 2a using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000477,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,960985,=,1,1,=,,Km,nM,,1500.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,1.5
104374,,,3482155,[],CHEMBL1265616,Activity of Aminoglycoside 2'-phosphotransferase 2a N196D/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000481,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,=,1,0,=,,Kcat,/s,,16.6,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,16.6
104375,,,3482162,[],CHEMBL1265616,Activity of Aminoglycoside 2'-phosphotransferase 2a N196D/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000477,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,960985,<,1,1,<,,Km,nM,,1000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,1.0
104376,,,3482169,[],CHEMBL1265617,Activity of Aminoglycoside 2'-phosphotransferase 2a R92H/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000481,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,=,1,0,=,,Kcat,/s,,26.7,CHEMBL612545,,Unchecked,,,,Kcat,/s,,,26.7
104377,,,3482176,[],CHEMBL1265617,Activity of Aminoglycoside 2'-phosphotransferase 2a R92H/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000477,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,960985,<,1,1,<,,Km,nM,,1000.0,CHEMBL612545,,Unchecked,,,,Km,uM,UO_0000065,,1.0
104378,,,3482183,[],CHEMBL1265618,Ratio of Kcat to Km for Aminoglycoside 2'-phosphotransferase 2a using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,=,1,0,=,,Kcat/Km,10'7/M/s,,1.7,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'7/M/s,,,1.7
104379,,,3482190,[],CHEMBL1265619,Ratio of Kcat to Km for Aminoglycoside 2'-phosphotransferase 2a N196D/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,>,1,0,>,,Kcat/Km,10'7/M/s,,1.7,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'7/M/s,,,1.7
104380,,,3482197,[],CHEMBL1265620,Ratio of Kcat to Km for Aminoglycoside 2'-phosphotransferase 2a R92H/D268N mutant using ATP/GTP as second substrate by spectrophotometric assay,B,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255425,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,960985,>,1,0,>,,Kcat/Km,10'7/M/s,,2.7,CHEMBL612545,,Unchecked,,,,Kcat/Km,10'7/M/s,,,2.7
104381,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3483955,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1267668,"Cmax in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,961516,=,1,1,=,,Cmax,nM,,705.85,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,0.33
104382,,,3483956,[],CHEMBL1267666,"Tmax in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0003037,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,Tmax,hr,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,min,UO_0000032,,15.0
104383,,,3483957,[],CHEMBL1267667,"Half life in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,T1/2,hr,,0.6935,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,min,UO_0000032,,41.61
104384,,,3483958,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267665,"AUClast in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,273.83,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUClast,microg.min/mL,,,16.43
104385,,,3483959,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267664,"AUC (0 to infinity) in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,315.67,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,microg.min/mL,,,18.94
104386,,,3483960,[],CHEMBL1267663,"Oral bioavailability in normally fed BALB/c mouse at 50 mg/kg, po",A,,,BAO_0003042,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,961516,=,1,1,=,,F,%,,0.48,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,%,UO_0000187,,0.48
104387,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3483961,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1267662,"Cmax in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0002119,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,961516,=,1,1,=,,Cmax,nM,,35207.05,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,16.46
104388,,,3483962,[],CHEMBL1267660,"Tmax in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0003037,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,Tmax,hr,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,min,UO_0000032,,15.0
104389,,,3483963,[],CHEMBL1267661,"Half life in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,T1/2,hr,,0.295,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,min,UO_0000032,,17.7
104390,,,3483964,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267659,"AUClast in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,10978.17,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUClast,microg.min/mL,,,658.69
104391,,,3483965,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAMUSCULAR', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAMUSCULAR', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267657,"AUC (0 to infinity) in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,11117.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,microg.min/mL,,,667.02
104392,,,3483966,[],CHEMBL1267658,"Oral bioavailability in normally fed BALB/c mouse at 10 mg/kg, im",A,,,BAO_0003042,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,961516,=,1,1,=,,F,%,,96.45,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,%,UO_0000187,,96.45
104393,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3483967,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1267656,"Cmax in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0002119,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,961516,=,1,1,=,,Cmax,nM,,75419.23,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,35.26
104394,,,3483968,[],CHEMBL1267654,"Tmax in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0003037,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,Tmax,hr,,0.08333,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,min,UO_0000032,,5.0
104395,,,3483969,[],CHEMBL1267655,"Half life in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,T1/2,hr,,0.3388,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,min,UO_0000032,,20.33
104396,,,3483970,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267653,"AUClast in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,11382.17,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUClast,microg.min/mL,,,682.93
104397,,,3483971,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '10.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '10.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAVENOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAVENOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267651,"AUC (0 to infinity) in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,11457.83,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,microg.min/mL,,,687.47
104398,,,3483972,[],CHEMBL1267652,"Oral bioavailability in normally fed BALB/c mouse at 10 mg/kg, iv",A,,,BAO_0003042,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,961516,=,1,1,=,,F,%,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,%,UO_0000187,,100.0
104399,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,3483973,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1267650,"Cmax in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002119,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/Nanomolar,961516,=,1,1,=,,Cmax,nM,,16683.78,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,ug ml-1,UO_0000065,,7.8
104400,,,3483974,[],CHEMBL1267648,"Tmax in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0003037,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,Tmax,hr,,0.25,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Tmax,min,UO_0000032,,15.0
104401,,,3483975,[],CHEMBL1267649,"Half life in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,961516,=,1,1,=,,T1/2,hr,,0.3662,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,t1/2,min,UO_0000032,,21.97
104402,,,3483976,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '0 - last', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': '0 - last', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267647,"AUClast in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,7061.33,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUClast,microg.min/mL,,,423.68
104403,,,3483977,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '50.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '50.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1267645,"AUC (0 to infinity) in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0002120,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961516,=,1,1,=,,AUC,ng.hr.mL-1,,7296.67,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,microg.min/mL,,,437.8
104404,,,3483978,[],CHEMBL1267646,"Oral bioavailability in 15 hrs fasted BALB/c mouse at 50 mg/kg, po",A,,,BAO_0003042,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255400,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,961516,=,1,1,=,,F,%,,12.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,F,%,UO_0000187,,12.4
104405,,,3489873,[],CHEMBL1264778,Antimicrobial activity against Pseudomonas aeruginosa M1251 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104406,,,3489874,[],CHEMBL1264782,Antimicrobial activity against Pseudomonas aeruginosa Z799/61 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104407,,,3489875,[],CHEMBL1264807,Antimicrobial activity against Pseudomonas aeruginosa isolate 13120 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104408,,,3489876,[],CHEMBL1264779,Antimicrobial activity against Pseudomonas aeruginosa R70 Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104409,,,3489877,[],CHEMBL1264780,Antimicrobial activity against Pseudomonas aeruginosa R20 Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104410,,,3489878,[],CHEMBL1264799,Antimicrobial activity against Pseudomonas aeruginosa isolate 1726 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104411,,,3489879,[],CHEMBL1264803,Antimicrobial activity against Pseudomonas aeruginosa isolate 1240 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104412,,,3489880,[],CHEMBL1264809,Antimicrobial activity against Pseudomonas aeruginosa isolate 17112 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104413,,,3489881,[],CHEMBL1264783,Antimicrobial activity against Pseudomonas aeruginosa 2779-con by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104414,,,3489882,[],CHEMBL1264805,Antimicrobial activity against Pseudomonas aeruginosa isolate 12102 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104415,,,3489883,[],CHEMBL1264784,Antimicrobial activity against Pseudomonas aeruginosa 1405-con D2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104416,,,3489884,[],CHEMBL1264786,Antimicrobial activity against Pseudomonas aeruginosa isolate 1693c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104417,,,3489885,[],CHEMBL1264800,Antimicrobial activity against Pseudomonas aeruginosa isolate 15107 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104418,,,3489886,[],CHEMBL1264785,Antimicrobial activity against Pseudomonas aeruginosa isolate 1530c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104419,,,3489887,[],CHEMBL1264789,Antimicrobial activity against Pseudomonas aeruginosa isolate 14169c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104420,,,3489888,[],CHEMBL1264801,Antimicrobial activity against Pseudomonas aeruginosa isolate 16008 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104421,,,3489889,[],CHEMBL1264802,Antimicrobial activity against Pseudomonas aeruginosa isolate 13167 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104422,,,3489890,[],CHEMBL1264806,Antimicrobial activity against Pseudomonas aeruginosa isolate 1253 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104423,,,3489891,[],CHEMBL1264790,Antimicrobial activity against Pseudomonas aeruginosa isolate 1247c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104424,,,3489892,[],CHEMBL1264793,Antimicrobial activity against Pseudomonas aeruginosa isolate 1333c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104425,,,3489893,[],CHEMBL1264798,Antimicrobial activity against Pseudomonas aeruginosa isolate 1495c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104426,,,3489894,[],CHEMBL1264787,Antimicrobial activity against Pseudomonas aeruginosa isolate 17145c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104427,,,3489895,[],CHEMBL1264788,Antimicrobial activity against Pseudomonas aeruginosa isolate 1529c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104428,,,3489896,[],CHEMBL1264791,Antimicrobial activity against Pseudomonas aeruginosa isolate 1681c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104429,,,3489897,[],CHEMBL1264792,Antimicrobial activity against Pseudomonas aeruginosa isolate 1352c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104430,,,3489898,[],CHEMBL1264797,Antimicrobial activity against Pseudomonas aeruginosa isolate 1712c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104431,,,3489899,[],CHEMBL1264794,Antimicrobial activity against Pseudomonas aeruginosa isolate 1248c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104432,,,3489900,[],CHEMBL1264808,Antimicrobial activity against Pseudomonas aeruginosa isolate 1665 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104433,,,3489901,[],CHEMBL1264781,Antimicrobial activity against Pseudomonas aeruginosa AHP Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
104434,,,3489902,[],CHEMBL1264795,Antimicrobial activity against Pseudomonas aeruginosa isolate 15110c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104435,,,3489903,[],CHEMBL1264796,Antimicrobial activity against Pseudomonas aeruginosa isolate 12142c from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104436,,,3489904,[],CHEMBL1264804,Antimicrobial activity against Pseudomonas aeruginosa isolate 3149 from fibrosis patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255447,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961800,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104437,,,3494101,[],CHEMBL1262951,Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa isolate PA/XY assessed as zone of inhibition by disk diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Millimeter,960093,<,1,1,<,,IZ,mm,,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,20.0
104438,,,3494115,[],CHEMBL1262939,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 8 ug/ml of amikacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104439,,,3494116,[],CHEMBL1262940,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 1 ug/ml of tobramycin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104440,,,3494117,[],CHEMBL1262941,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 4ug/ml of gentamycin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104441,,,3494118,[],CHEMBL1262942,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 1 ug/ml of oflaxacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104442,,,3494119,[],CHEMBL1262943,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrZ mutant and MexZ mutant gene selected after 1 ug/ml of Norfloxacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104443,,,3494120,[],CHEMBL1262944,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 0.25 ug/ml of ciprofloxacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104444,,,3494121,[],CHEMBL1262945,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY agrW mutant and MexZ mutant gene selected after 4 ug/ml of cefepime exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104445,,,3494122,[],CHEMBL1262946,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 8 ug/ml of amikacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104446,,,3494123,[],CHEMBL1262947,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 0.25 ug/ml of ciprofloxacin exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104447,,,3494124,[],CHEMBL1262948,Antimicrobial activity against MexXY-OprM-overproducing Pseudomonas aeruginosa PAO1 harboring MexY and MexZ mutant gene selected after 4 ug/ml of cefepime exposure,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104448,,,3494125,[],CHEMBL1263419,Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa PAO1,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104449,,,3494126,[],CHEMBL1262950,Antimicrobial activity against mexXY-OprM-overproducing Pseudomonas aeruginosa clinical isolate,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255270,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960093,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104450,,,3495569,[],CHEMBL1263777,Antibacterial activity against 16S rRNA methylase RmtB and CTX-M-65 ESBL producing Escherichia coli isolate ECRB1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255282,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961727,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104451,,,3495576,[],CHEMBL1263779,Antibacterial activity against 16S rRNA methylase rmtB and CTX-M-65 ESBL producing rifampin resistant Escherichia coli isolate ECRB1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255282,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961727,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104452,,,3495577,[],CHEMBL1263780,Antibacterial activity against 16S rRNA methylase RmtB and CTX-M-65 ESBL producing Escherichia coli DH10B by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255282,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961727,>=,1,1,>=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
104453,,,3495582,[],CHEMBL1263778,Antibacterial activity against Escherichia coli DH10B harboring pBCSK expressing rmtB gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255282,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961727,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104454,,,3497198,[],CHEMBL1264066,Antibacterial activity against Acinetobacter genomosp. 3 isolates by broth micro dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255492,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960859,>=,1,1,>=,,MIC,ug.mL-1,,0.5,CHEMBL3140321,Acinetobacter pittii,Acinetobacter pittii,48296.0,,,MIC,ug ml-1,UO_0000274,,0.5
104455,,,3497211,[],CHEMBL1264066,Antibacterial activity against Acinetobacter genomosp. 3 isolates by broth micro dilution,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255492,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960859,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL3140321,Acinetobacter pittii,Acinetobacter pittii,48296.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104456,,,3497224,[],CHEMBL1264066,Antibacterial activity against Acinetobacter genomosp. 3 isolates by broth micro dilution,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255492,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960859,>=,1,1,>=,,MIC90,ug.mL-1,,16.0,CHEMBL3140321,Acinetobacter pittii,Acinetobacter pittii,48296.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104457,,,3497237,[],CHEMBL1264067,Antibacterial activity against Acinetobacter genomosp. 3 isolates assessed as percent of resistance isolates by broth micro dilution,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255492,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,960859,=,1,0,=,,Activity,%,,42.1,CHEMBL3140321,Acinetobacter pittii,Acinetobacter pittii,48296.0,,,Activity,%,UO_0000187,,42.1
104458,,Active,3509291,[],CHEMBL1268323,Antimicrobial activity against Acinetobacter baumannii ATCC 15151 harboring ISAba1-blaOXA-23 gene by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255451,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961125,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104459,,Active,3509302,[],CHEMBL1268711,Antimicrobial activity against Acinetobacter baumannii ATCC 15151 harboring ISAba1-blaOXA-66 gene by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255451,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,961125,,1,0,,,Activity,,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,,,,
104460,,,3509305,[],CHEMBL1268713,Antimicrobial activity against Acinetobacter sp. harboring aacA4 gene assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255451,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,961125,=,1,0,=,,Activity,%,,66.0,CHEMBL614427,Acinetobacter sp.,Acinetobacter sp.,472.0,,,Activity,%,UO_0000187,,66.0
104461,,,3511095,[],CHEMBL1264324,Antimicrobial activity against amikacin-resistant Nocardia farcinica IFM 10580 after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960041,>,1,1,>,,MIC,ug.mL-1,,1024.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,,MIC,ug ml-1,UO_0000274,,1024.0
104462,,,3511109,[],CHEMBL1264325,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960041,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,,MIC,ug ml-1,UO_0000274,,64.0
104463,,,3511123,[],CHEMBL1264326,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 harboring 16s rRNA A1408G mutant after 5 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960041,>,1,1,>,,MIC,ug.mL-1,,1024.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,,MIC,ug ml-1,UO_0000274,,1024.0
104464,,,3511137,[],CHEMBL1264434,Antimicrobial activity against amikacin-susceptible Nocardia farcinica IFM 10152 after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1255473,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960041,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL613232,Nocardia farcinica,Nocardia farcinica,37329.0,,,MIC,ug ml-1,UO_0000274,,32.0
104465,,,3533918,[],CHEMBL1279525,Antimicrobial activity against Pseudomonas aeruginosa isolate PA-SD2 harboring blaVIM-1 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275500,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969877,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104466,,,3533919,[],CHEMBL1279526,Antimicrobial activity against Pseudomonas aeruginosa isolate PA-SL2 harboring blaVIM-13 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275500,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969877,=,1,1,=,,MIC,ug.mL-1,,48.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,48.0
104467,,,3533920,[],CHEMBL1279532,Antimicrobial activity against Escherichia coli XL1-Blue harboring pGEM-T carrying aacA4 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275500,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969877,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
104468,,,3533921,[],CHEMBL1279533,Antimicrobial activity against Escherichia coli XL1-Blue harboring pGEM-T carrying aacA4 Ala108Thr mutant gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275500,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969877,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
104469,,,3533922,[],CHEMBL1279534,Antimicrobial activity against Escherichia coli XL1-Blue by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275500,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969877,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104470,,,3534021,[],CHEMBL1280221,"Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104471,,,3534048,[],CHEMBL1280222,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104472,,,3534075,[],CHEMBL1280223,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104473,,,3534102,[],CHEMBL1280224,Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.12
104474,,,3534129,[],CHEMBL1280225,Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104475,,,3534156,[],CHEMBL1280226,Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970581,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104476,,,3534777,[],CHEMBL1286720,Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained from dog with urinary tract infection by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969902,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104477,,,3534799,[],CHEMBL1286723,Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969902,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104478,,,3534821,[],CHEMBL1286726,Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969902,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
104479,,,3539732,[],CHEMBL1287328,Antimicrobial against Pseudomonas aeruginosa PAO1 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104480,,,3539733,[],CHEMBL1287329,Antimicrobial against Pseudomonas aeruginosa 33410 harboring phoU allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104481,,,3539734,[],CHEMBL1280762,Antimicrobial against Pseudomonas aeruginosa 30848 harboring phoU allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104482,,,3539735,[],CHEMBL1280763,Antimicrobial against Pseudomonas aeruginosa 32455 harboring phzS allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104483,,,3539736,[],CHEMBL1280764,Antimicrobial against Pseudomonas aeruginosa 3208 harboring phzM allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104484,,,3539737,[],CHEMBL1280765,Antimicrobial against Pseudomonas aeruginosa 3434 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104485,,,3539738,[],CHEMBL1280766,Antimicrobial against Pseudomonas aeruginosa 3894 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104486,,,3539739,[],CHEMBL1280767,Antimicrobial against Pseudomonas aeruginosa 1494 harboring phnA allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104487,,,3539740,[],CHEMBL1280768,Antimicrobial against Pseudomonas aeruginosa 40198 harboring nirJ allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104488,,,3539741,[],CHEMBL1280769,Antimicrobial against Pseudomonas aeruginosa 8564 harboring pyrX allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104489,,,3539742,[],CHEMBL1280770,Antimicrobial against Pseudomonas aeruginosa 9256 harboring ybhO allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
104490,,,3539743,[],CHEMBL1280771,Antimicrobial against Pseudomonas aeruginosa 8666 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104491,,,3539744,[],CHEMBL1280772,Antimicrobial against Pseudomonas aeruginosa 3465 harboring tsaA allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104492,,,3539745,[],CHEMBL1280773,Antimicrobial against Pseudomonas aeruginosa 312 harboring PBPP allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104493,,,3539746,[],CHEMBL1280774,Antimicrobial against Pseudomonas aeruginosa 46396 harboring katA allele by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275522,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970740,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.2
104494,,,3541972,[],CHEMBL1283200,Antimicrobial activity against Acinetobacter baumannii-calcoaceticus obtained from war-wounded patient assessed as susceptible isolates,F,,,BAO_0001103,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275597,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,970610,=,1,0,=,,Activity,%,,56.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,56.0
104495,,,3544297,[],CHEMBL1284061,Antimicrobial activity against rmtB positive Escherichia coli VOG producing beta lactamase CTX-M-14 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104496,,,3544298,[],CHEMBL1284062,"Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG1 expressing RmtB, TEM-1, and QepA gene by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104497,,,3544299,[],CHEMBL1284063,Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG2 expressing CTX-M-14 and AAC(6 )-Ib gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.0
104498,,,3544300,[],CHEMBL1284064,Antimicrobial activity against armB positive Escherichia coli COP producing beta lactamase CTX-M-14 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104499,,,3544301,[],CHEMBL1284065,Antimicrobial activity against armA positive Escherichia coli TOP10 harboring plasmid COP1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104500,,,3544302,[],CHEMBL1284066,Antimicrobial activity against beta lactamase CTX-M-14 producing Escherichia coli TOP10 harboring plasmid COP2 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
104501,,,3544303,[],CHEMBL1284067,Antimicrobial activity against armA positive Escherichia coli MEZ producing beta lactamase CTX-M-3 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104502,,,3544304,[],CHEMBL1284068,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid MEZ by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104503,,,3544305,[],CHEMBL1284069,Antimicrobial activity against armA positive Enterobacter cloacae BEH producing beta lactamase CTX-M-3 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
104504,,,3544306,[],CHEMBL1284070,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid BEH by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104505,,,3544307,[],CHEMBL1284071,Antimicrobial activity against armA positive Klebsiella pneumoniae DU producing beta lactamase CTX-M-3 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,256.0
104506,,,3544308,[],CHEMBL1284072,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid DU by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,256.0
104507,,,3544309,[],CHEMBL1284073,Antimicrobial activity against Escherichia coli TOP10 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970135,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.38
104508,,,3544413,[],CHEMBL1284229,Antimicrobial activity against Enterobacter cloacae expressing beta-lactamase KPC-2 and SHV-12 obtained from criticall ill liver transplant recipient by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275572,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970679,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,8.0
104509,,,3544427,[],CHEMBL1284231,Antimicrobial activity against Pseudomonas putida expressing beta-lactamase KPC-2 and SHV-12 obtained from criticall ill liver transplant recipient by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275572,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970679,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL612501,Pseudomonas putida,Pseudomonas putida,303.0,,,MIC,ug ml-1,UO_0000274,,8.0
104510,,,3546819,[],CHEMBL1282792,Antibacterial activity against nonpigmented rapidly growing Mycobacterium abscessus after 3 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104511,,,3546828,[],CHEMBL1282793,Antibacterial activity against nonpigmented rapidly growing Mycobacterium chelonae after 3 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC50,ug ml-1,UO_0000274,,4.0
104512,,,3546837,[],CHEMBL1282918,Antibacterial activity against nonpigmented rapidly growing Mycobacterium peregrinum after 3 days by broth microdilution method,F,,,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL4296581,Mycolicibacterium peregrinum,Mycolicibacterium peregrinum,43304.0,,,MIC50,ug ml-1,UO_0000274,,4.0
104513,,,3546846,[],CHEMBL1282919,Antibacterial activity against nonpigmented rapidly growing Mycobacterium fortuitum after 3 days by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104514,,,3546855,[],CHEMBL1282792,Antibacterial activity against nonpigmented rapidly growing Mycobacterium abscessus after 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104515,,,3546864,[],CHEMBL1282793,Antibacterial activity against nonpigmented rapidly growing Mycobacterium chelonae after 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104516,,,3546873,[],CHEMBL1282918,Antibacterial activity against nonpigmented rapidly growing Mycobacterium peregrinum after 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL4296581,Mycolicibacterium peregrinum,Mycolicibacterium peregrinum,43304.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104517,,,3546882,[],CHEMBL1282919,Antibacterial activity against nonpigmented rapidly growing Mycobacterium fortuitum after 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104518,,,3546891,[],CHEMBL1282920,Antibacterial activity against nonpigmented rapidly growing Mycobacterium mucogenicum after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
104519,,,3546901,[],CHEMBL1282921,Antibacterial activity against nonpigmented rapidly growing Mycobacterium mageritense after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612959,Mycolicibacterium mageritense,Mycolicibacterium mageritense,53462.0,,,MIC,ug ml-1,UO_0000274,,8.0
104520,,,3546911,[],CHEMBL1282922,Antibacterial activity against nonpigmented rapidly growing Mycobacterium alvei after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,4.0
104521,,,3546921,[],CHEMBL1282923,Antibacterial activity against nonpigmented rapidly growing Mycobacterium smegmatis after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.03
104522,,,3546931,[],CHEMBL1282924,Antibacterial activity against nonpigmented rapidly growing Mycobacterium porcinum after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
104523,,,3546941,[],CHEMBL1282925,Antibacterial activity against nonpigmented rapidly growing Mycobacterium septicum after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
104524,,,3546951,[],CHEMBL1282926,Antibacterial activity against nonpigmented rapidly growing Mycobacterium wolinskyi after 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275537,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970895,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,8.0
104525,,,3549061,[],CHEMBL1284560,Antimicrobial activity against Pseudomonas aeruginosa isolate PA465 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104526,,,3549062,[],CHEMBL1284599,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA459,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104527,,,3549063,[],CHEMBL1284602,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA483,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104528,,,3549064,[],CHEMBL1284603,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA494,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104529,,,3549065,[],CHEMBL1284604,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA507,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104530,,,3549117,[],CHEMBL1284597,Antimicrobial activity against Pseudomonas aeruginosa isolate PA500 expressing VIM-1 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104531,,,3550317,[],CHEMBL1284558,Antimicrobial activity against Pseudomonas aeruginosa isolate PA399 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104532,,,3550318,[],CHEMBL1284559,Antimicrobial activity against Pseudomonas aeruginosa isolate PA462 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104533,,,3550319,[],CHEMBL1284561,Antimicrobial activity against Pseudomonas aeruginosa isolate PA469 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104534,,,3550320,[],CHEMBL1284562,Antimicrobial activity against Pseudomonas aeruginosa isolate PA475 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104535,,,3550321,[],CHEMBL1284595,Antimicrobial activity against Pseudomonas aeruginosa isolate PA477 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104536,,,3550322,[],CHEMBL1284596,Antimicrobial activity against Pseudomonas aeruginosa isolate PA481 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104537,,,3550323,[],CHEMBL1284598,Antimicrobial activity against Pseudomonas aeruginosa isolate PA510 expressing VIM-2 beta-lactamase,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104538,,,3550324,[],CHEMBL1284600,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA460,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104539,,,3550325,[],CHEMBL1284601,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA479,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104540,,,3550326,[],CHEMBL1284605,Antimicrobial activity against metallo-beta-lactamase-negative Pseudomonas aeruginosa isolate PA509,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275252,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970768,>=,1,1,>=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104541,,,3566373,[],CHEMBL1279838,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as planktonic cells assessed as concentration and time required inactivate 1 log bacterial cells,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,Activity,mg.min/L,,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,mg.min/L,,,20.0
104542,,Active,3566374,[],CHEMBL1279839,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as biofilms,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104543,,,3566375,[],CHEMBL1279840,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction in bacterial count at 10 mg/L after 50 mins by plate count method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,FC,,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,1.5
104544,,,3566376,[],CHEMBL1279841,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction in bacterial count at 10 mg/L after 50 mins by CTC staining,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,FC,,,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,0.9
104545,,,3566377,[],CHEMBL1279842,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction in bacterial count at 10 mg/L after 50 mins by BacLight Live/Dead staining,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,FC,,,0.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,0.2
104546,,,3566378,[],CHEMBL1279843,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as biofilm assessed as membrane integrity by BacLight Live/Dead staining,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,969556,=,1,0,=,,Activity,%,,70.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,70.0
104547,,Active,3566379,[],CHEMBL1279844,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as biofilm assessed as respiratory activity by CTC-DAPI staining,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104548,,,3566380,[],CHEMBL1279845,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as planktonic cells assessed as concentration and time required inactivate 2 log bacterial cells,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,Activity,mg.min/L,,30.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,mg.min/L,,,30.0
104549,,,3566381,[],CHEMBL1279846,Antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as biofilm assessed as concentration and time required inactivate 2 log bacterial cells,F,,,BAO_0000181,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,Activity,mg.min/L,,1000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,mg.min/L,,,1000.0
104550,,,3566382,[],CHEMBL1279847,Ratio of antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as biofilm assessed as concentration and time required inactivate 2 log bacterial cells to antimicrobial activity against Pseudomonas aeruginosa PAO1 grown as planktonic cells assessed as concentration and time required inactivate 2 log bacterial cells,F,,,BAO_0000193,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275406,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969556,=,1,0,=,,Ratio,,,33.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,33.0
104551,,,3567556,[],CHEMBL1279819,Antibacterial activity against Pseudomonas aeruginosa PAO1 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104552,,,3567557,[],CHEMBL1279820,Antibacterial activity against Pseudomonas aeruginosa FE60 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104553,,,3567558,[],CHEMBL1279821,Antibacterial activity against Pseudomonas aeruginosa EryR by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104554,,,3567559,[],CHEMBL1279822,Antibacterial activity against Pseudomonas aeruginosa EryR harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104555,,,3567560,[],CHEMBL1279823,Antibacterial activity against Pseudomonas aeruginosa FK06 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104556,,,3567561,[],CHEMBL1279824,Antibacterial activity against Pseudomonas aeruginosa FK06 harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104557,,,3567562,[],CHEMBL1279825,Antibacterial activity against Pseudomonas aeruginosa 3308 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.12
104558,,,3567563,[],CHEMBL1279826,Antibacterial activity against Pseudomonas aeruginosa 3308 harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104559,,,3567564,[],CHEMBL1279827,Antibacterial activity against Pseudomonas aeruginosa 2439 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104560,,,3567565,[],CHEMBL1279828,Antibacterial activity against Pseudomonas aeruginosa 2439 harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104561,,,3567566,[],CHEMBL1279829,Antibacterial activity against Pseudomonas aeruginosa 2126 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104562,,,3567567,[],CHEMBL1279830,Antibacterial activity against Pseudomonas aeruginosa 2126 harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104563,,,3567568,[],CHEMBL1279965,Antibacterial activity against Pseudomonas aeruginosa 1956 by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104564,,,3567569,[],CHEMBL1279966,Antibacterial activity against Pseudomonas aeruginosa 1956 harboring pNF225 carrying nfxB by twofold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275455,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969732,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104565,,,3567859,[],CHEMBL1278659,Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969562,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,50.0
104566,,,3567879,[],CHEMBL1278660,Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay in presence of 250 ug/ml polyethylenimine,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969562,=,1,1,=,,MIC,ug.mL-1,,240.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,240.0
104567,,,3567899,[],CHEMBL1278661,"FIC index, ratio of MIC for Pseudomonas aeruginosa 100609 in presence of 250 ug/ml polyethylenimine to MIC for Pseudomonas aeruginosa 100609",F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,969562,=,1,0,=,,FICI,,,4.81,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,4.81
104568,,,3569155,[],CHEMBL1279357,Antibacterial activity against Pseudomonas aeruginosa 1750J expressing beta-lactamase IMP-15 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275418,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969644,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104569,,,3569359,[],CHEMBL1278942,Antimicrobial activity against Acinetobacter genospecies 3 isolate Ac057 expressing beta-lactamase Oxa-58 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275464,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969835,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3140321,Acinetobacter pittii,Acinetobacter pittii,48296.0,,,MIC,ug ml-1,UO_0000274,,0.25
104570,,,3569375,[],CHEMBL1278943,Antimicrobial activity against Acinetobacter baumannii isolate Ac058 expressing beta-lactamase Oxa-58 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275464,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969835,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,64.0
104571,,,3569519,[],CHEMBL1279215,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone A expressing beta-lactamase Oxa-48, TEM-1, SHV-12 and Oxa-9 by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275467,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969836,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
104572,,,3569530,[],CHEMBL1279216,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone B expressing beta-lactamase Oxa-48, TEM-1, CTX-M-15 and Oxa-1 by Etest",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275467,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969836,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
104573,,,3570197,[],CHEMBL1278331,Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-15 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104574,,,3570199,[],CHEMBL1278333,Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-16 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104575,,,3570201,[],CHEMBL1278335,Antimicrobial activity against Escherichia coli DH5alpha harboring beta-lactamase VIM-2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104576,,,3570203,[],CHEMBL1278337,Antimicrobial activity against Escherichia coli DH5alpha by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104577,,,3570243,[],CHEMBL1278327,Antimicrobial activity against Pseudomonas aeruginosa 9551 expressing beta-lactamase VIM-15 obtained from urine of patient by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104578,,,3570295,[],CHEMBL1278329,Antimicrobial activity against Pseudomonas aeruginosa 166301 expressing beta-lactamase VIM-16 obtained from urine of patient by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1275469,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969760,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
104579,,,5079877,[],CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,,,BAO_0003041,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1310558,=,1,1,=,,Vdss,L.kg-1,,0.23,CHEMBL612558,,ADMET,,,,Vdss,L/kg,UO_0000197,,0.23
104580,,,5080962,[],CHEMBL1614672,Fraction unbound in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1310558,=,1,1,=,,Fu,,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,fu,,,,1.0
104581,,,5081341,[],CHEMBL1614671,Clearance in human after iv administration,A,,,BAO_0002759,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1310558,=,1,1,=,,CL,mL.min-1.kg-1,,1.6,CHEMBL612558,,ADMET,,,,CL,mL/min/kg,,,1.6
104582,,,5081545,[],CHEMBL1614674,Half life in human after iv administration,A,,,BAO_0002115,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1310558,=,1,1,=,,T1/2,hr,,2.0,CHEMBL612558,,ADMET,,,,t1/2,h,UO_0000032,,2.0
104583,,,5081719,[],CHEMBL1614673,Mean residence time in human after iv administration,A,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1614632,Drug Metab Dispos,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1310558,=,1,1,=,,MRT,hr,,2.4,CHEMBL612558,,ADMET,,,,MRT,h,UO_0000032,,2.4
104584,,Active,5083803,[],CHEMBL1615363,Phospholipidosis-positive literature compound observed in rat,A,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1615345,J Chem Inf Model,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1311647,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
104585,,Active,5083804,[],CHEMBL1615362,Phospholipidosis-positive literature compound observed in human,A,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1615345,J Chem Inf Model,2007.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1311647,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
104586,,,5087324,[],CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104587,,,5087333,[],CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104588,,,5087342,[],CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.5
104589,,,5088093,[],CHEMBL1637253,Antimicrobial activity against Escherichia coli expressing beta-lactamase SHV by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104590,,,5088102,[],CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104591,,,5088111,[],CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104592,,,5088120,[],CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104593,,,5088129,[],CHEMBL1637246,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
104594,,,5088138,[],CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
104595,,,5088147,[],CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
104596,,,5088156,[],CHEMBL1637256,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on multiple determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.5
104597,,,5088165,[],CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104598,,,5088174,[],CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104599,,,5088183,[],CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,8.0
104600,,,5088192,[],CHEMBL1637259,Antimicrobial activity against Klebsiella pneumoniae expressing extended-spectrum beta-lactamase and beta-lactamase AmpC by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
104601,,,5088201,[],CHEMBL1637260,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase DHA by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104602,,,5088210,[],CHEMBL1637261,Antimicrobial activity against Proteus mirabilis expressing extended-spectrum beta-lactamase by Etest based on single determinant,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.5
104603,,,5088219,[],CHEMBL1637262,Antimicrobial activity against Proteus mirabilis expressing extended-spectrum beta-lactamase by Etest based on multiple determinants,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,4.0
104604,,,5088228,[],CHEMBL1637263,Antimicrobial activity against Proteus mirabilis expressing beta-lactamase AmpC by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,4.0
104605,,,5088237,[],CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104606,,,5088246,[],CHEMBL1637250,Antimicrobial activity against Escherichia coli extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104607,,,5088255,[],CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104608,,,5088264,[],CHEMBL1637251,Antimicrobial activity against Klebsiella pneumoniae extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104609,,,5088273,[],CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104610,,,5088282,[],CHEMBL1637252,Antimicrobial activity against Proteus mirabilis extended-spectrum beta-lactamase producing isolate by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104611,,,5088291,[],CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104612,,,5088300,[],CHEMBL1637254,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104613,,,5088309,[],CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104614,,,5088318,[],CHEMBL1637249,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104615,,,5088327,[],CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104616,,,5088336,[],CHEMBL1637248,Antimicrobial activity against Escherichia coli expressing beta-lactamase CTX and SHV by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104617,,,5088345,[],CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104618,,,5088354,[],CHEMBL1637245,Antimicrobial activity against Escherichia coli expressing beta-lactamase AmpC and extended-spectrum beta-lactamase by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104619,,,5088363,[],CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104620,,,5088372,[],CHEMBL1637255,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV by Etest based on single determinant,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104621,,,5088381,[],CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104622,,,5088390,[],CHEMBL1637257,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on single determinant,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104623,,,5088399,[],CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104624,,,5088408,[],CHEMBL1637247,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase CTX by Etest based on multiple determinants,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104625,,,5088417,[],CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104626,,,5088426,[],CHEMBL1637258,Antimicrobial activity against Klebsiella pneumoniae expressing beta-lactamase SHV and CTX by Etest,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629612,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312989,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104627,,,5094984,[],CHEMBL1633206,Antibacterial activity against Klebsiella pneumoniae A expressing CTX-M group 1 beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
104628,,,5094985,[],CHEMBL1633204,Antibacterial activity against Klebsiella pneumoniae B expressing CTX-M group 1 beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
104629,,,5094986,[],CHEMBL1633205,Antibacterial activity against Klebsiella pneumoniae C expressing CTX-M group 1 beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
104630,,,5095023,[],CHEMBL1635692,Antibacterial activity against rifampicin resistant Escherichia coli J53-2 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
104631,,,5095059,[],CHEMBL1635690,Antibacterial activity against Escherichia coli TrC A expressing Klebsiella pneumoniae A blaCTX-M beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
104632,,,5095060,[],CHEMBL1635687,Antibacterial activity against Escherichia coli TrC B expressing Klebsiella pneumoniae B blaCTX-M beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
104633,,,5095061,[],CHEMBL1633392,Antibacterial activity against Escherichia coli TrC C expressing Klebsiella pneumoniae C blaCTX-M beta-lactamase by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629585,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314367,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104634,,,5096047,[],CHEMBL1635207,Antimicrobial activity against Acinetobacter radioresistens 251-39C expressing beta-lactamase OXA-133 by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629591,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314517,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL2366968,Acinetobacter radioresistens,Acinetobacter radioresistens,40216.0,,,MIC,ug ml-1,UO_0000274,,2.0
104635,,,5096048,[],CHEMBL1635208,Antimicrobial activity against plasmid encoded beta-lactamase OXA-58 deficient Acinetobacter radioresistens by CLSI method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629591,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314517,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL2366968,Acinetobacter radioresistens,Acinetobacter radioresistens,40216.0,,,MIC,ug ml-1,UO_0000274,,2.0
104636,,,5096775,[],CHEMBL1636732,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,0.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10cfu,,,,0.2
104637,,,5096783,[],CHEMBL1636728,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,0.86,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,0.86
104638,,,5096790,[],CHEMBL1636733,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 2000 microamperes of electric current by bioelectric effect assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,3.08,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,log10cfu,,,,3.08
104639,,,5096799,[],CHEMBL1636729,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 2000 microamperes of electric current by bioelectric effect assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,2.0
104640,,,5096802,[],CHEMBL1636725,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,1.69,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,1.69
104641,,,5096805,[],CHEMBL1636727,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 200 microamperes of electric current by bioelectric effect assay,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1312941,=,1,0,=,,log10cfu,,,2.48,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,2.48
104642,,,5096813,[],CHEMBL1636724,Antimicrobial activity against Staphylococcus epidermidis Xen 43 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312941,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
104643,,,5096821,[],CHEMBL1635872,Antimicrobial activity against Staphylococcus aureus Xen 30 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312941,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
104644,,,5096823,[],CHEMBL1635871,Antimicrobial activity against Pseudomonas aeruginosa Xen 5 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312941,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104645,,,5099565,[],CHEMBL1640892,Antimicrobial activity against Pseudomonas aeruginosa isolate 243-31C expressing beta-lactamase VIM-18 isolated from sputum of patient by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313029,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104646,,Not Determined,5099587,[],CHEMBL1641040,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-18 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1313029,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
104647,,Not Determined,5099588,[],CHEMBL1641041,Antimicrobial activity against Escherichia coli harboring beta-lactamase VIM-2 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1313029,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
104648,,Not Determined,5099589,[],CHEMBL1641042,Antimicrobial activity against Escherichia coli harboring plasmid pPCRScript by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1629661,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1313029,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
104649,,,5141650,[],CHEMBL1656334,Antimicrobial activity against Pseudomonas aeruginosa isolate M136074 expressing IMP-22 beta lactamase gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325825,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104650,,,5141651,[],CHEMBL1656467,Antimicrobial activity against Pseudomonas aeruginosa isolate 26285 expressing IMP-13 beta lactamase gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325825,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
104651,,,5141652,[],CHEMBL1656468,Antimicrobial activity against Pseudomonas aeruginosa isolate 22843 expressing VIM-2 beta lactamase gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325825,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104652,,,5141653,[],CHEMBL1656469,Antimicrobial activity against Pseudomonas aeruginosa isolate 27135 expressing VIM-2 beta lactamase gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649164,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325825,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104653,,,5144970,[],CHEMBL1665423,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 biofilm assessed as log reduction of viable cells after 24 hrs relative to wild-type Escherichia coli K-12 BW25113,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326413,=,1,0,=,,FC,,,760.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,760.0
104654,,,5144974,[],CHEMBL1665425,Effect on survival of Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as increase in cell survival after 24 hrs pretreated with 5 uM of IPTG for 4 hrs relative to wild-type Escherichia coli K-12 BW25114,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326413,=,1,0,=,,FC,,,3300.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,3300.0
104655,,Not Active,5144976,[],CHEMBL1665426,Bactericidal activity against Escherichia coli K-12 BW25113 biofilm harboring pCA24N ptac::yafQ plasmid assessed as log reduction of viable cells after 24 hrs pretreated with 5 uM of IPTG for 4 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326413,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
104656,,,5144980,[],CHEMBL1665427,Antimicrobial activity against Escherichia coli K-12 BW25113 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326413,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.5
104657,,,5144984,[],CHEMBL1665428,Antimicrobial activity against yafQ gene-deficient Escherichia coli K-12 BW25113 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326413,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
104658,,Active,5144989,[],CHEMBL1665429,Bactericidal activity against yafQ gene-deficient Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326413,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
104659,,Active,5144990,[],CHEMBL1665430,Bactericidal activity against Escherichia coli K-12 BW25113 stationary-phase planktonic cell assessed as log reduction of viable cells after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649452,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326413,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
104660,,,5146499,[],CHEMBL1666003,Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ798 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326504,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104661,,,5146500,[],CHEMBL1666004,Antimicrobial activity against Pseudomonas aeruginosa isolate IMCJ799 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326504,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104662,,,5146501,[],CHEMBL1666011,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326504,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
104663,,,5146502,[],CHEMBL1666012,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf wild type gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326504,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
104664,,,5146503,[],CHEMBL1666013,Antimicrobial activity against Escherichia coli JM109 transformant harboring pSTV28 plasmid expressing aac(6')-Iaf (TTG-ATG) mutant gene by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649468,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326504,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
104665,,Active,5148898,[],CHEMBL1662445,Antimicrobial activity against extended spectrum beta-lactamase CTX-M-2-producing Pseudomonas aeruginosa isolate P6208,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649177,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326017,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104666,,,5149317,[],CHEMBL1667510,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.5
104667,,,5149318,[],CHEMBL1667511,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutY::Gm mutant gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.5
104668,,,5149319,[],CHEMBL1667512,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutT::Gm mutant gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.5
104669,,,5149320,[],CHEMBL1667513,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutM::Gm mutant gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.5
104670,,,5149321,[],CHEMBL1667519,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of Ceftazidime by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.75
104671,,,5149322,[],CHEMBL1667520,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of Ceftazidime by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104672,,,5149323,[],CHEMBL1667521,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of Ceftazidime by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104673,,,5149324,[],CHEMBL1667522,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of Ceftazidime by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104674,,,5149325,[],CHEMBL1667523,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of tobramycin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,6.0
104675,,,5149326,[],CHEMBL1667524,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of tobramycin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,3.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.75
104676,,,5149327,[],CHEMBL1667525,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of tobramycin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,3.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.5
104677,,,5149328,[],CHEMBL1667526,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of tobramycin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.9
104678,,,5149329,[],CHEMBL1667527,Antimicrobial activity against Pseudomonas aeruginosa PAO1 selected in presence of ciprofloxacin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.06
104679,,,5149330,[],CHEMBL1667528,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene selected in presence of ciprofloxacin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.37,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.37
104680,,,5149331,[],CHEMBL1667529,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutM mutant gene selected in presence of ciprofloxacin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.19,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.19
104681,,,5149332,[],CHEMBL1665502,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene selected in presence of ciprofloxacin by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326440,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.25
104682,,Active,5149333,[],CHEMBL1665623,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutT mutant gene complemented with wild type DNA oxidative repair system mutT gene,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326440,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104683,,Active,5149334,[],CHEMBL1665624,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutY mutant gene complemented with wild type DNA oxidative repair system mutY gene,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326440,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104684,,Active,5149335,[],CHEMBL1667518,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system mutL mutant gene complemented with wild type DNA oxidative repair system mutY gene,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326440,,1,0,,,Activity,,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,,,,
104685,,,5149338,[],CHEMBL1667514,Antimicrobial activity against Pseudomonas aeruginosa PAO1 assessed as microbial doubling time,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1326440,=,1,1,=,,TIME,hr,,0.4333,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,min,UO_0000032,,26.0
104686,,,5149343,[],CHEMBL1667515,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutY::Gm mutant gene assessed as doubling time,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1326440,=,1,1,=,,TIME,hr,,0.4283,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,min,UO_0000032,,25.7
104687,,,5149348,[],CHEMBL1667516,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutT::Gm mutant gene assessed as doubling time,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1326440,=,1,1,=,,TIME,hr,,0.4617,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,min,UO_0000032,,27.7
104688,,,5149353,[],CHEMBL1667517,Antimicrobial activity against Pseudomonas aeruginosa PAO1 harboring DNA oxidative repair system deltamutM::Gm mutant gene assessed as doubling time,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649458,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Hour,1326440,=,1,1,=,,TIME,hr,,0.455,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,min,UO_0000032,,27.3
104689,,,5150567,[],CHEMBL1666821,Antimicrobial activity against Acinetobacter baumannii 3208 expressing multiple-antibiotic resistance gene AbaR5 by Viek 2 system,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649484,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326711,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
104690,,,5150731,[],CHEMBL1664928,Antimicrobial activity against Extended-spectrum beta-lactamase producing Escherichia coli clinical isolate assessed as resistant isolate,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649487,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1326720,=,1,0,=,,Activity,%,,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,50.0
104691,,,5154554,[],CHEMBL1655555,Antimicrobial activity against Pseudomonas aeruginosa isolate 3066 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104692,,,5154555,[],CHEMBL1655554,Antimicrobial activity against Pseudomonas aeruginosa isolate 2998 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104693,,,5154556,[],CHEMBL1655553,Antimicrobial activity against Pseudomonas aeruginosa isolate 2933 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104694,,,5154557,[],CHEMBL1655552,Antimicrobial activity against Pseudomonas aeruginosa isolate 2858 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104695,,,5154558,[],CHEMBL1655551,Antimicrobial activity against Pseudomonas aeruginosa isolate 2804 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104696,,,5154559,[],CHEMBL1655550,Antimicrobial activity against Pseudomonas aeruginosa isolate 2729 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104697,,,5154560,[],CHEMBL1655549,Antimicrobial activity against Pseudomonas aeruginosa isolate 2721 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104698,,,5154561,[],CHEMBL1655548,Antimicrobial activity against Pseudomonas aeruginosa isolate 2716 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104699,,,5154562,[],CHEMBL1655547,Antimicrobial activity against Pseudomonas aeruginosa isolate 2715 obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104700,,,5154563,[],CHEMBL1655546,Antimicrobial activity against Pseudomonas aeruginosa isolate 3020R obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
104701,,,5154564,[],CHEMBL1655545,Antimicrobial activity against Pseudomonas aeruginosa isolate 3020S obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104702,,,5154565,[],CHEMBL1655544,Antimicrobial activity against Pseudomonas aeruginosa isolate 615R obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104703,,,5154566,[],CHEMBL1655543,Antimicrobial activity against Pseudomonas aeruginosa isolate 615S obtained from cystic fibrosis patient by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104704,,,5154567,[],CHEMBL1655542,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F1018L mutant by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104705,,,5154568,[],CHEMBL1655541,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY F29S mutant by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104706,,,5154569,[],CHEMBL1655540,Antimicrobial activity against ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant transformed with pAGH97 carrying mexXY operon by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104707,,,5154570,[],CHEMBL1655539,Antimicrobial activity against mexXY deficient ampicillin- and ticarcillin-resistant Pseudomonas aeruginosa FE60 mutant by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
104708,,,5154571,[],CHEMBL1655538,Antimicrobial activity against Pseudomonas aeruginosa mutGR1 overexpressing mexXY mutant by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104709,,,5154572,[],CHEMBL1655537,Antimicrobial activity against Pseudomonas aeruginosa PAO1 by twofold macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326129,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104710,,,5154694,[],CHEMBL1655661,Ratio of MIC for Pseudomonas aeruginosa 615R to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104711,,,5154695,[],CHEMBL1655662,Ratio of MIC for Pseudomonas aeruginosa 3020R to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104712,,,5154696,[],CHEMBL1655663,Ratio of MIC for Pseudomonas aeruginosa 2715 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104713,,,5154697,[],CHEMBL1655665,Ratio of MIC for Pseudomonas aeruginosa 2721 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104714,,,5154698,[],CHEMBL1655666,Ratio of MIC for Pseudomonas aeruginosa 2729 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104715,,,5154699,[],CHEMBL1655667,Ratio of MIC for Pseudomonas aeruginosa 2804 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104716,,,5155797,[],CHEMBL1655669,Ratio of MIC for Pseudomonas aeruginosa 2933 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104717,,,5155798,[],CHEMBL1655670,Ratio of MIC for Pseudomonas aeruginosa 2998 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104718,,,5155799,[],CHEMBL1655671,Ratio of MIC for Pseudomonas aeruginosa 3066 to MIC for Pseudomonas aeruginosa PAO1,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649198,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1326129,>=,1,0,>=,,FC,,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,4.0
104719,,,5159924,[],CHEMBL1653746,Antimicrobial activity against azide-resistant Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104720,,,5159936,[],CHEMBL1653733,Antimicrobial activity against Enterobacter cloacae isolate 101 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
104721,,,5159954,[],CHEMBL1653739,Antimicrobial activity against Escherichia coli isolate 48 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104722,,,5159958,[],CHEMBL1653737,Antimicrobial activity against Escherichia coli isolate 17 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104723,,,5159959,[],CHEMBL1653738,Antimicrobial activity against Escherichia coli isolate 48 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104724,,,5159960,[],CHEMBL1653741,Antimicrobial activity against Klebsiella pneumoniae isolate 132 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104725,,,5159992,[],CHEMBL1653730,Antimicrobial activity against Enterobacter cloacae isolate 37 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,16.0
104726,,,5159993,[],CHEMBL1653731,Antimicrobial activity against Enterobacter cloacae isolate 37 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,16.0
104727,,,5159994,[],CHEMBL1653732,Antimicrobial activity against Enterobacter cloacae isolate 101 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,16.0
104728,,,5159995,[],CHEMBL1653734,Antimicrobial activity against Enterobacter cloacae isolate 153 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,16.0
104729,,,5159996,[],CHEMBL1653735,Antimicrobial activity against Enterobacter cloacae isolate 153 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,16.0
104730,,,5159997,[],CHEMBL1653736,Antimicrobial activity against Escherichia coli isolate 17 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
104731,,,5159998,[],CHEMBL1653740,Antimicrobial activity against Klebsiella pneumoniae isolate 132 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104732,,,5159999,[],CHEMBL1653742,Antimicrobial activity against Klebsiella pneumoniae isolate 135 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104733,,,5160000,[],CHEMBL1653743,Antimicrobial activity against Klebsiella pneumoniae isolate 135 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104734,,,5160001,[],CHEMBL1653744,Antimicrobial activity against Klebsiella pneumoniae isolate 202 expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104735,,,5160002,[],CHEMBL1653745,Antimicrobial activity against Klebsiella pneumoniae isolate 202 transconjugant expressing aac(6')-Ib-cr gene,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326340,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
104736,,,5166285,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104737,,,5166293,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.5
104738,,,5166302,[],CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,68.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,68.4
104739,,,5166309,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
104740,,,5166317,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,0.12
104741,,,5166324,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC50,ug ml-1,UO_0000274,,0.12
104742,,Not Active,5166331,[],CHEMBL1667172,Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,Activity,,,,
104743,,,5166338,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,0.06
104744,,,5166345,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,128.0
104745,,,5166352,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,128.0
104746,,Not Active,5166359,[],CHEMBL1667171,Antibacterial activity against vancomycin- resistant Enterococcus faecium assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,,,,
104747,,,5166366,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,2.0
104748,,,5166373,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,128.0
104749,,,5166380,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104750,,Not Active,5166387,[],CHEMBL1667170,Antibacterial activity against vancomycin- resistant Enterococcus faecalis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
104751,,,5166394,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
104752,,,5166406,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
104753,,,5166413,[],CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,27.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,27.3
104754,,,5166422,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104755,,,5166430,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104756,,,5166438,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.008
104757,,,5166445,[],CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,33.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,33.3
104758,,,5166454,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.03
104759,,Not Active,5166462,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
104760,,,5166470,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
104761,,,5166478,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.015
104762,,,5166486,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.015
104763,,,5166494,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC,ug ml-1,UO_0000274,,0.03
104764,,,5166502,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.008
104765,,,5166510,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.015
104766,,,5167004,[],CHEMBL1654343,Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104767,,,5167013,[],CHEMBL1654344,Antibacterial activity against Pseudomonas aeruginosa NY214 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104768,,,5167022,[],CHEMBL1654345,Antibacterial activity against Pseudomonas aeruginosa NY215 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104769,,,5167031,[],CHEMBL1654346,Antibacterial activity against Pseudomonas aeruginosa NY217 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104770,,,5167040,[],CHEMBL1654347,Antibacterial activity against Pseudomonas aeruginosa NY219 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104771,,,5167049,[],CHEMBL1654348,Antibacterial activity against Pseudomonas aeruginosa NY220 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649275,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322916,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
104772,,,5167564,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104773,,,5167572,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104774,,,5167580,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104775,,,5167588,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC50,ug ml-1,UO_0000274,,0.12
104776,,,5167596,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.015
104777,,,5167604,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104778,,Not Active,5167612,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
104779,,,5167620,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104780,,,5167628,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104781,,,5167636,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC90,ug ml-1,UO_0000274,,32.0
104782,,,5167644,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.06
104783,,,5167652,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104784,,,5167659,[],CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,16.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,16.7
104785,,,5167667,[],CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,26.7,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,26.7
104786,,,5167675,[],CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,16.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,16.0
104787,,,5167683,[],CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,46.7,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,46.7
104788,,,5167691,[],CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,54.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,Activity,%,UO_0000187,,54.5
104789,,,5167699,[],CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,34.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,Activity,%,UO_0000187,,34.0
104790,,,5167707,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.015
104791,,,5167715,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.008
104792,,,5167723,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC,ug ml-1,UO_0000274,,0.008
104793,,,5167731,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.008
104794,,,5167739,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104795,,,5167747,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
104796,,,5167755,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104797,,,5167763,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.06
104798,,,5167771,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104799,,,5167779,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
104800,,,5167787,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104801,,,5167795,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,8.0
104802,,,5167803,[],CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,73.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,73.0
104803,,,5167811,[],CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,74.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,74.0
104804,,,5167819,[],CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,74.0,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,Activity,%,UO_0000187,,74.0
104805,,,5167827,[],CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,74.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,74.0
104806,,,5167835,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
104807,,,5167842,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
104808,,Not Active,5167849,[],CHEMBL1667186,Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
104809,,Not Active,5167856,[],CHEMBL1667187,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,,,,
104810,,,5167863,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104811,,,5167870,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104812,,,5167877,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104813,,,5167884,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104814,,,5167892,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
104815,,,5168585,[],CHEMBL1659805,Antibacterial activity against Pseudomonas aeruginosa isolated from wound infection of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649281,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322966,=,1,1,=,,MIC,ug.mL-1,,48.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,48.0
104816,,,5168586,[],CHEMBL1659806,Antibacterial activity against Pseudomonas aeruginosa isolated from lung biopsy specimen of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649281,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322966,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104817,,,5168587,[],CHEMBL1659804,Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649281,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322966,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104818,,,5168588,[],CHEMBL1659803,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring Pseudomonas aeruginosa plasmid DNA isolated from wound infection of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649281,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322966,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.0
104819,,,5168589,[],CHEMBL1659802,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring Pseudomonas aeruginosa plasmid DNA lung biopsy specimen of patient by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649281,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322966,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.0
104820,,,5168984,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
104821,,,5168991,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.008
104822,,,5168999,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,0.008
104823,,,5169007,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,0.008
104824,,,5169015,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.008
104825,,,5169023,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,0.008
104826,,,5169031,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC,ug ml-1,UO_0000274,,0.008
104827,,,5169039,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,0.008
104828,,,5169047,[],CHEMBL1667188,Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.06
104829,,,5169055,[],CHEMBL1667189,Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,95.5
104830,,,5169063,[],CHEMBL1667190,Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,Activity,%,UO_0000187,,95.5
104831,,,5169071,[],CHEMBL1667191,Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,Activity,%,UO_0000187,,95.5
104832,,,5169079,[],CHEMBL1667192,Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,Activity,%,UO_0000187,,95.5
104833,,,5169087,[],CHEMBL1667193,Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,Activity,%,UO_0000187,,95.5
104834,,,5169095,[],CHEMBL1667194,Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,Activity,%,UO_0000187,,95.5
104835,,,5169103,[],CHEMBL1667195,Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,Activity,%,UO_0000187,,95.5
104836,,,5169111,[],CHEMBL1667196,Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.5,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,Activity,%,UO_0000187,,95.5
104837,,,5169120,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,16.0
104838,,,5169128,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,16.0
104839,,,5169135,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104840,,,5169143,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104841,,,5169151,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104842,,,5169159,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104843,,,5169167,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104844,,,5169175,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104845,,,5169183,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104846,,,5169192,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,16.0
104847,,,5169200,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
104848,,,5169207,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104849,,,5169215,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104850,,,5169223,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104851,,,5169231,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104852,,,5169239,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104853,,,5169247,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104854,,,5169255,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104855,,,5169262,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.12
104856,,,5169268,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.06
104857,,,5169275,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,0.03
104858,,,5169282,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.03
104859,,,5169290,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,4.0
104860,,,5169296,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC50,ug ml-1,UO_0000274,,0.25
104861,,,5169303,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC50,ug ml-1,UO_0000274,,0.06
104862,,,5169310,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,0.25
104863,,,5169318,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104864,,,5169924,[],CHEMBL1659034,Antimicrobial activity against Pseudomonas aeruginosa isolate 1036 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.125
104865,,,5169925,[],CHEMBL1659035,Antimicrobial activity against Pseudomonas aeruginosa isolate 944 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,96.0
104866,,,5169926,[],CHEMBL1659036,Antimicrobial activity against Pseudomonas aeruginosa isolate 1050 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104867,,,5169927,[],CHEMBL1659037,Antimicrobial activity against Pseudomonas aeruginosa isolate 1060 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,0.75,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.75
104868,,,5169928,[],CHEMBL1659038,Antimicrobial activity against Pseudomonas aeruginosa isolate 1095 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104869,,,5169929,[],CHEMBL1659039,Antimicrobial activity against Pseudomonas aeruginosa isolate 22 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104870,,,5169930,[],CHEMBL1659040,Antimicrobial activity against Pseudomonas aeruginosa isolate 878 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.5
104871,,,5169931,[],CHEMBL1659041,Antimicrobial activity against Pseudomonas aeruginosa isolate 896 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,24.0
104872,,,5169932,[],CHEMBL1659042,Antimicrobial activity against Pseudomonas aeruginosa isolate 988 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
104873,,,5169933,[],CHEMBL1659043,Antimicrobial activity against Pseudomonas aeruginosa isolate 1006 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
104874,,,5169934,[],CHEMBL1659044,Antimicrobial activity against Pseudomonas aeruginosa isolate 856 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
104875,,,5169935,[],CHEMBL1659045,Antimicrobial activity against Pseudomonas aeruginosa isolate 913 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,96.0
104876,,,5169936,[],CHEMBL1659046,Antimicrobial activity against Pseudomonas aeruginosa isolate 927 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
104877,,,5169937,[],CHEMBL1659047,Antimicrobial activity against Pseudomonas aeruginosa isolate 968 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,96.0
104878,,,5169938,[],CHEMBL1659048,Antimicrobial activity against Pseudomonas aeruginosa isolate 971 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.5
104879,,,5169939,[],CHEMBL1659049,Antimicrobial activity against Pseudomonas aeruginosa isolate 821 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
104880,,,5169940,[],CHEMBL1659050,Antimicrobial activity against Pseudomonas aeruginosa isolate 1080 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
104881,,,5169941,[],CHEMBL1659051,Antimicrobial activity against Pseudomonas aeruginosa isolate 1093 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649285,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322994,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
104882,,,5169996,[],CHEMBL1659864,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323253,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104883,,,5170006,[],CHEMBL1659864,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323253,>=,1,1,>=,,MIC90,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104884,,,5170016,[],CHEMBL1659865,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323253,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,32.0
104885,,,5170265,[],CHEMBL1663502,Drug absorption in human assessed as human intestinal absorption rate,A,,,BAO_0000179,BAO_0000221,tissue-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649380,Eur J Med Chem,2011.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1325471,=,1,0,=,,log10(%HIA +10),,,1.0,CHEMBL612558,,ADMET,,,,log10(%HIA +10),,,,1.0
104886,,,5170370,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104887,,,5170377,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC90,ug ml-1,UO_0000274,,0.5
104888,,,5170384,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,0.5
104889,,,5170392,[],CHEMBL1667197,Antibacterial activity against Acinetobacter baumannii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,60.4,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,60.4
104890,,,5170398,[],CHEMBL1667198,Antibacterial activity against Acinetobacter calcoaceticus assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,92.6,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,Activity,%,UO_0000187,,92.6
104891,,,5170405,[],CHEMBL1667199,Antibacterial activity against Acinetobacter lwoffii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,94.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,Activity,%,UO_0000187,,94.0
104892,,,5170412,[],CHEMBL1667200,Antibacterial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,99.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,99.0
104893,,,5170421,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.25
104894,,Not Active,5170428,[],CHEMBL1667201,Antibacterial activity against Citrobacter koseri assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,Activity,,,,
104895,,,5170437,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC50,ug ml-1,UO_0000274,,0.5
104896,,,5170445,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104897,,,5170453,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.25
104898,,,5170459,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.12
104899,,,5170466,[],CHEMBL1667202,Antibacterial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,Activity,%,UO_0000187,,100.0
104900,,,5170473,[],CHEMBL1667203,Antibacterial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
104901,,,5170481,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC50,ug ml-1,UO_0000274,,0.5
104902,,,5170487,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.25
104903,,,5170495,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104904,,,5170501,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104905,,,5170509,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
104906,,,5170516,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
104907,,Not Active,5170523,[],CHEMBL1667204,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
104908,,Not Active,5170530,[],CHEMBL1667205,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,,,,
104909,,,5170537,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104910,,,5170544,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,4.0
104911,,,5170551,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104912,,,5170558,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104913,,,5170566,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.25
104914,,Not Active,5170573,[],CHEMBL1667206,Antibacterial activity against Klebsiella oxytoca assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,,,,
104915,,,5170582,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,0.5
104916,,,5170590,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104917,,,5170597,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.12
104918,,,5170603,[],CHEMBL1667207,Antibacterial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,100.0
104919,,,5170611,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.25
104920,,,5170618,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104921,,,5170625,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC,ug ml-1,UO_0000274,,0.03
104922,,,5170632,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.015
104923,,Not Active,5170640,[],CHEMBL1667208,Antibacterial activity against Legionella pneumophila assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,Activity,,,,
104924,,,5170647,[],CHEMBL1667209,Antibacterial activity against Moraxella catarrhalis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,100.0
104925,,,5170655,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC50,ug ml-1,UO_0000274,,0.12
104926,,,5170662,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.03
104927,,,5170670,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104928,,,5170677,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.03
104929,,,5170686,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.25
104930,,Not Active,5170693,[],CHEMBL1667210,Antibacterial activity against Morganella morganii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1327198,,1,0,,,Activity,,,,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,,,,
104931,,,5170702,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104932,,,5171067,[],CHEMBL1659865,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323253,>=,1,1,>=,,MIC90,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,64.0
104933,,,5171077,[],CHEMBL1659970,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates assessed as susceptible isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1323253,=,1,0,=,,Activity,%,,10.8,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,10.8
104934,,,5171084,[],CHEMBL1659971,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates assessed as susceptible isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1323253,=,1,0,=,,Activity,%,,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,8.0
104935,,,5171098,[],CHEMBL1659976,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae isolates assessed as resistance isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1323253,=,1,0,=,,Activity,%,,76.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,76.5
104936,,,5171099,[],CHEMBL1659977,Antimicrobial activity against beta lactamase KPC-producing Klebsiella pneumoniae isolates assessed as resistance isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649286,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1323253,=,1,0,=,,Activity,%,,92.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,92.0
104937,,,5171752,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,4.0
104938,,,5171782,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.25
104939,,,5171788,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.25
104940,,,5171795,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
104941,,,5171802,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
104942,,,5171809,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.12
104943,,,5171816,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,8.0
104944,,,5171823,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,2.0
104945,,,5171831,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104946,,,5171837,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC50,ug ml-1,UO_0000274,,1.0
104947,,,5171844,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,2.0
104948,,,5171851,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104949,,,5171858,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.5
104950,,,5171865,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104951,,,5171872,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,8.0
104952,,,5171880,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,4.0
104953,,,5171886,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC90,ug ml-1,UO_0000274,,4.0
104954,,,5171893,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,2.0
104955,,,5171900,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104956,,,5171907,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,1.0
104957,,,5171914,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104958,,,5171921,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327198,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,8.0
104959,,,5171928,[],CHEMBL1667339,Antibacterial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,100.0
104960,,,5171935,[],CHEMBL1667340,Antibacterial activity against Proteus vulgaris assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,Activity,%,UO_0000187,,100.0
104961,,,5171942,[],CHEMBL1667341,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,95.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,95.2
104962,,,5171949,[],CHEMBL1667342,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,44.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,44.8
104963,,,5171956,[],CHEMBL1667343,Antibacterial activity against levofloxacin susceptible Serratia marcescens assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,100.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,100.0
104964,,,5171963,[],CHEMBL1667344,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,0.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,0.0
104965,,,5171970,[],CHEMBL1667346,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia assessed as assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1327198,=,1,0,=,,Activity,%,,1.9,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,1.9
104966,,,5173171,[],CHEMBL1667374,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321830,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.25
104967,,,5173172,[],CHEMBL1667375,Antimicrobial activity against Pseudomonas aeruginosa isolate NH57388A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321830,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.5
104968,,,5173182,[],CHEMBL1667386,Toxicity in Pseudomonas aeruginosa ATCC 27853 infected Swiss mouse,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1321830,=,1,0,=,,MTD,mg Kg-1,,60.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,MTD,mg Kg-1,UO_0000308,,60.0
104969,,,5173185,[],CHEMBL1667388,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as mouse survival rate at 120 mg/kg BID administered 24 hrs post infection through aerosol,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1321830,=,1,0,=,,Activity,%,,60.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,60.0
104970,,,5173186,[],CHEMBL1667390,Bactericidal activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 60 mg/kg BID administered 24 hrs post infection through aerosol,F,,,BAO_0000179,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1321830,=,1,0,=,,log10cfu,,,2.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,2.9
104971,,,5173508,[],CHEMBL1654654,Antimicrobial activity against Escherichia coli J53,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649246,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322452,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
104972,,,5173530,[],CHEMBL1654655,Antimicrobial activity against Escherichia coli J53 harboring pEK499 plasmid encoding CTX-M extended-spectrum beta-lactamases,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649246,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322452,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104973,,,5173552,[],CHEMBL1654656,Antimicrobial activity against Escherichia coli J53 harboring pEK204 plasmid encoding CTX-M extended-spectrum beta-lactamases,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649246,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322452,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104974,,,5173574,[],CHEMBL1654657,Antimicrobial activity against Escherichia coli DH5[alpha],F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649246,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322452,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
104975,,,5173596,[],CHEMBL1654658,Antimicrobial activity against Escherichia coli DH5[alpha] harboring pEK516 plasmid encoding CTX-M extended-spectrum beta-lactamases,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649246,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322452,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
104976,,,5177799,[],CHEMBL1659076,Antibacterial activity against CTX-M-15 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,100.0
104977,,,5177800,[],CHEMBL1659077,Antibacterial activity against SHV-12 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,89.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,89.0
104978,,,5177801,[],CHEMBL1659078,Antibacterial activity against CTX-M-14 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
104979,,,5177802,[],CHEMBL1659079,Antibacterial activity against CTX-M-15 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,97.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,97.0
104980,,,5177803,[],CHEMBL1659080,Antibacterial activity against CTX-M-15 and SHV-27 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
104981,,,5177804,[],CHEMBL1659081,Antibacterial activity against CTX-M-15 and SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
104982,,,5177805,[],CHEMBL1659082,Antibacterial activity against SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,100.0
104983,,,5177806,[],CHEMBL1659083,Antibacterial activity against CTX-M-14 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,67.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,67.0
104984,,,5177807,[],CHEMBL1659084,Antibacterial activity against CTX-M-15 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,96.0
104985,,,5177808,[],CHEMBL1659085,Antibacterial activity against SHV-12 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,83.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,83.0
104986,,,5177809,[],CHEMBL1659086,Antibacterial activity against CTX-M-14 ESBL producing Morganella morganii assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,100.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,%,UO_0000187,,100.0
104987,,,5177810,[],CHEMBL1659087,Antibacterial activity against CTX-M-14 ESBL producing Proteus mirabilis assessed as resistant isolates by disk diffusion method,F,,,BAO_0001103,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649259,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://qudt.org/vocab/unit#Percent,1322790,=,1,0,=,,Activity,%,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,0.0
104988,,,5177998,[],CHEMBL1659896,Antibacterial activity against Pseudomonas aeruginosa PAO1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649262,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322819,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
104989,,,5178009,[],CHEMBL1659899,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring plasmid pA1 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649262,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322819,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
104990,,Not Active,5178200,[],CHEMBL1658207,Antimicrobial activity against ESBL producing Escherichia coli assessed as resistant isolates by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649309,Antimicrob Agents Chemother,2010.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1323711,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
104991,,,5179111,[],CHEMBL1659895,"Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A1 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649262,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322819,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104992,,,5179112,[],CHEMBL1659897,"Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A2 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649262,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322819,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104993,,,5179113,[],CHEMBL1659898,"Antibacterial activity against mexB and mexY expressing Pseudomonas aeruginosa PA-A3 harboring GyrA T83I, ParC S87L and IS1001 insertion at position 629 in OprD gene by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649262,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322819,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
104994,,,5180335,[],CHEMBL1659698,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321956,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,25.0
104995,,Not Determined,5180357,[],CHEMBL1659699,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1321956,,1,0,,,MIC,,,,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,,,,
104996,,,5180377,[],CHEMBL1659700,Antimicrobial activity against Mycobacterium chelonae 9917 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321956,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,25.0
104997,,Not Determined,5180399,[],CHEMBL1659701,Antimicrobial activity against Mycobacterium chelonae 9917 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,,1321956,,1,0,,,MIC,,,,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,,,,
104998,,,5209827,[],CHEMBL1678980,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 1 expressing ampC, ompA, adeB, adeM by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331744,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
104999,,,5209828,[],CHEMBL1678990,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 6 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL1747,TOBRAMYCIN,CHEMBL1747,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331744,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
